Download the Monday Daily - American Association for Clinical ...

president ’s Welcome 

PreParing for 

the future Welcome to the 

world’s premier 

international 

event for clinical 

laboratorians, the 

2008 AACC Annual 

Meeting and 

Larry Broussard, PhD 

Clinical Lab Expo. 

AACC is proud 

to host this meeting in Washington, 

D.C., capital of the United States 

and home of our national office. I 

extend a warm welcome to everyone, 

especially ASCLS members, who are 

holding their annual meeting with 

us this week. I also want to recognize 

the efforts of the many other societies, 

too numerous to list here, that 

participated in putting together this 

week’s program. 

Education, networking, and 

exposition are the three pillars of 

the 2008 Annual Meeting. The 2008 

Annual Meeting Organizing Committee, 

led by Ann Gronowski, PhD, 

deserves special congratulations for 

developing a scientific program that 

disseminates the latest information 

on developments in laboratory 

medicine, including presentations 

on areas such as pharmacogenomics, 

autoimmune disease, toxicology, 

molecular diagnostics, cancer, and 

much more. 

This meeting provides unparalleled 

opportunities to spend time 

with your peers from around the 

world. In addition to the many 

educational sessions, special interest 

group meetings and social events 

abound, giving every attendee the 

opportunity to spend time with familiar 

colleagues, as well as meet new 

colleagues with common interests. 

I know from my own personal experience 

that AACC offers so much 

more than just scientific sessions. 

Take this opportunity to network 

and build relationships that will 

maintain their value after you return 

home. I have made many lifelong 

friends at this annual event, and it is 

wonderful to see them every year. 

The Clinical Lab Expo, the largest 

event of its kind, is the place to see 

all the newest products and services 

for clinical labs. I extend a warm 

welcome to all our colleagues from 

the many companies, both large and 

small, that are present at this year’s 

exposition. Companies work hard all 

year to debut their newest innovations 

at AACC, and I applaud them 

for helping advance the field of laboratory 

medicine. Many attendees tell 

me that they return to their lab each 

year armed with the information 

they need to make critical purchasing 

decisions for their organizations. 

As you network with colleagues 

and peers from around the world 

this week, I think you will gain a 

greater appreciation for the global 

nature of clinical chemistry today. I 

hope you enjoy your week in Washington 

and that you leave with information 

that will help you advance 

the practice and profession of clinical 

laboratory science and its application 

to healthcare in your workplace. 

T h e M o n D a y Co n v e n T i o n Da i Ly 

Clinical 

Laboratory 

News 

Is Warfarin Pharmacogenomic 

Testing Ready for Prime Time? 

Today’s Debate to Focus on Implementation Issues 

By DeBorah Levenson 

in recent years, personalized medicine has become the subject 

of much hype in newspapers and magazines, although it 

has yet to become a part of routine healthcare. But with an 

August 2007 update to the warfarin package insert, FDA may 

have nudged patient care closer to an era in which genetic information 

helps tailor care for millions. The updated insert makes 

clinicians aware that patients with certain variants of the CYP2C9 

and VKORC1 genes probably need lower initial doses. But despite 

FDA’s suggestion that warfarin pharmacogenomic assays might aid 

dosing, use of such tests remains controversial. 

While most experts on pharmacogenomic testing say it holds 

great potential for patient care, they disagree about whether now 

is the time to implement it widely. “Everyone says personalized 

medicine is the wave of the future, but the question is really the 

rate at which it is rolled out,” said Michael Hallworth, FRCPath, 

Consultant Clinical Scientist at Royal Shrewsbury Hospital in 

Shropshire, U.K. “Warfarin genomic testing is like the poster child 

for personalized medicine because it addresses diseases that affect 

millions. It’s a paradigm for widespread adoption of genomic testing.” Hallworth is moderator of a debate titled 

“Warfarin Pharmacogenomic Testing: Now Ready for Prime Time?” scheduled for 10:30 a.m. in room 150AB 

of the Walter E. Washington Convention Center. 

See Warfarin debate, continued on page 8 

A Global Perspective on Healthcare 

Conference Program Puts Spotlight on Needs of 

Developing World 

By BiLL MaLone 

last year Paul Yager, PhD, Professor and Acting Chair of the Department of Bioengineering at the 

University of Washington, Seattle, made a trip to South Africa to attend a meeting for principal investigators 

of the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health initiative. 

During his stay, Yager visited a township with an HIV infection rate of 29% and very hight rate of TB 

infection. While walking around this very poor area, he noticed a lot of the locals using cell phones. 

“So I whipped out my cell phone—from Seattle—flipped it open, and I got five bars. And then I went and took a 

picture with my phone, and that picture ended up back in my hotel on my laptop before I got there. So I asked a 

guy, ‘Does everyone have cell phones here? And he said ‘Oh, yes, everyone.’ And he took a look at my phone and 

said, ‘And most of ours are much nicer than yours.’” 

Yager wasn’t visiting South Africa to study cell phones—he’s developing a rugged POC device for infectious 

diseases—but the ubiquity of cell phones there represents a solid example of how certain technologies have 

been able to ‘leapfrog’ older technologies and penetrate regions of the world that are remote, very poor, and 

experiencing severe health problems—areas referred to as low-resource settings. “You look at that situation and 

say, ‘If that technology can make it, how can we piggyback on that existing cell phone technology, for example, 

and use the strength of that in order to bring in relatively sophisticated diagnostic equipment?’ ” Yager said. He is 

one of three speakers at today’s afternoon symposium “Diagnostics for the Developing World,” in room 146C. 

Bala Manian, PhD, of RealMetrix (San Carlos, Calif.) and Hans-Georg Batz, PhD, of ArteBioConsulting 

(Tutzing, Germany) will also be speaking. 

The symposium is one of several events at the 2008 AACC Annual Meeting that fall under the rubric 

of global health, a subject that has interested Ann Gronowski, PhD, Chair of the 2008 Annual Meeting 

See Global healthcare, continued on page 46 

The auThoriTaTive 

source for The 

clinical laboraTorian 

july 28, 2008 

special ediTion 

www.aacc.org 

in This issue 

3 

6 

8 

9 

10 

Plenary Speakers: 

Vagelos, Blackburn 

Industry Workshops 

Cokie Roberts Speaks at 

Special Event Today 

AACC Thanks 

Corporate Sponsors 

Congratulations to the 

2008 AACC Award Winners 

12 Student 

Oral Presentations 

NACB Honors 

Award Winners 

14 

14 

20 

NACB Distinguished 

Abstract Awards 

2008 New Product Review


Laboratory 

News 

ediTorial sTaff 

editor—Nancy Sasavage, PhD 

senior editors—John Bell, Phil Kibak, 

Deborah Levenson 

Managing editor—Bill Malone 

business sTaff 

v.p. strategic initiatives and 

business development—Joseph Perrone, ScD 

circulation Manager—Mickie Napoleoni 

board of ediTors 

chair—Jack A. Maggiore, PhD, 

BioSafe Laboratories, Chicago, Ill. 

Members—Nikola Baumann, PhD, 

University of Illinois Medical Center at 

Chicago, Chicago, Ill. 

Thomas Daly, MD, 

Eli Lilly and Company, Indianapolis, Ind. 

David Grenache, PhD, University of Utah and 

ARUP Laboratories, Salt Lake City, Utah. 

Elia M. Mears, MS, MT (ASCP), SM 

Chabert Medical Center, Houma, La. 

Alan T. Remaley, MD, PhD, 

National Institutes of Health, Bethesda, Md. 

aacc officers 

president—Larry A. Broussard, PhD 

president-elect—Barbara Goldsmith, PhD 

Treasurer—Ann Gronowski, PhD 

secretary—Anthony W. Butch, PhD 

past-president—Gary L. Myers, PhD 

adverTisinG sales 

Scherago International, Inc. 

525 Washington Blvd, Ste. 3310 

Jersey City, NJ 07310 

Phone: (201) 653-4777, Fax: (201) 653-5705 

E-mail: aacc@scherago.com 

president—H.L. Burklund 

vice president sales—Jack Ryan 

Marketing director—Steven A. Hamburger 

Traffic Manager—Roni Jackling 

subscripTions 

American Association for Clinical Chemistry, Inc. 

1850 K Street, NW, Suite 625 

Washington, DC 20006 

Phone: (202) 857-0717 or (800) 892-1400 

Fax: (202) 887-5093 

E-mail: custserv@aacc.org 

Subscriptions to Clinical Laboratory News are 

free to qualified laboratory professionals in 

the United States. AACC members outside 

the U.S. pay $72 for postage. The subscription 

price for those who do not qualify for a 

free subscription is $72/year in the U.S. and 

$109/year outside the U.S. Back issues may be 

ordered for $10 as available. For more information, 

contact the AACC Customer Service 

Department at (800) 892-1400 or 

(202) 857-0717 or custserv@aacc.org. 

ediTorial correspondence 

Nancy Sasavage, PhD, Editor 

Clinical Laboratory News 

1850 K Street, NW, Suite 625 

Washington, DC 20006 

Phone: (202) 835-8725 or (800) 892-1400 

Fax: (202) 835-8725 

E-mail: nsasavage@aacc.org 

Contents copyright © 2008 by the American 

Association for Clinical Chemistry, Inc., 

except as noted. Printed in the U.S.A. 

Clinical Laboratory News (ISSN 0161-9640) 

is the authoritative source for timely analysis 

of issues and trends affecting clinical 

laboratories, clinical laboratorians, and the 

practice of clinical laboratory science. 

P l e n a ry SPeaker SP ot l i g h t 

sunday’s plenary speaker, 

p. roy vagelos, Md 

P. Roy Vagelos, MD, is Chairman of Regeneron 

Pharmaceuticals, Inc. (Tarrytown, 

N.Y.) and Theravance, Inc. (South San 

Francisco, Calif.). In addition to his business 

activities, he is an active alumnus of 

Columbia University School of Medicine. 

Dr. Vagelos chairs a board of visitors at 

Columbia that advises the Dean on strategies 

and issues. He joined pharmaceutical 

giant Merck & Co. in 1975 as Senior Vice 

President of Research and became President 

of its research division one year later. 

In 1982 he became Senior Vice President of 

the company, and in 1984 he was elected to 

the Board of Directors and became Merck’s 

Executive Vice President. He served as 

Chairman from 1986-1994. 

Monday’s plenary speaker, 

elizabeth h. blackburn, phd 

Elizabeth Blackburn, PhD, in 1985 discovered 

telomerase, an enzyme associated with 

uncontrolled proliferation of cells. Seen in 

as many as 90% of all cancers, telomerase 

is considered by many to be an ideal target 

for developing broadly effective anti-cancer 

drugs. First identified in human tumors in 

the mid-1990s, telomerase replenishes the 

ends of eukaryotic chromosomes, known 

as telomeres, in a process that guards against 

the scrambling of genetic information. 

The UCSF professor’s lab also discovered 

that chemical inhibitors of telomerase 

cause human cell telomeres to shorten and 

that certain mutant telomerases impair 

cell division. Blackburn and her team are 

now applying these finding to an anticancer 

strategy in human breast, prostate, and 

bladder cancer cells. 

P. Roy Vagelos, MD 

The changing pharmaceutical industry 

sunday, july 27, 5:00 p.m.–6:30 p.m. 

current position: Chairman, Regeneron Pharmaceuticals, Inc., and 

Theravance, Inc. 

education: Columbia University, New York, N.Y., MD; Internship and 

residency at Massachusetts General Hospital, Boston, Mass. 

previous positions: Senior Surgeon and Head of Section of Biochemistry, 

National Heart Institute, National Institutes of Health (Bethesda, Md.); Chair, 

Department of Biological Chemistry, and Director, Division of Biology and 

Biochemistry, Washington University School of Medicine (St. Louis, Mo.); 

Chief Executive Officer, Merck & Co. (Whitehouse Station, N.J.). 

Dr. Vangelos’s contributions have earned 

him numerous awards and honors. In 1972 

he was elected to the National Academy of 

Sciences and the American Academy of 

Arts and Sciences. Other awards he has received 

include: the Lawrence A. Wien Prize 

in Social Responsibility from Columbia 

University, the C. Walter Nichols Award 

from the Stern School of Business of New 

York University, the National Academy of 

Science Award for Chemistry in Service to 

Society, the Prince Mahidol Award from 

the Prince Mahidol Award Foundation 

(Bangkok,Thailand), the Othmer Gold 

Medal from the Chemical Heritage Foundation, 

and the Bower Award in Business 

Leadership from the Franklin Institute. 

Elizabeth H. Blackburn, PhD 

Telomerase and Telomere biology 

Monday, july 21, 8:45 p.m.–10:15 a.m. 

In addition, he has received 14 honorary 

degrees. 

In his plenary talk, Dr. Vagelos will address 

the ups and downs of the pharmaceutical 

industry, from its “golden age” of the 

1970s, 1980s, and 1990s, to being an industry 

“in a funk.” During its golden age, the 

industry was extolled for its accomplishments 

in increasing lifespan and improving 

overall quality of life. But results of a 2004 

Harris Poll indicated that people regarded 

the industry negatively, putting it on a par 

with tobacco and oil companies. Dr. Vagelos 

believes the industry is going through a 

pause as it ushers in an important new age 

of discovery in functional genomics and 

personalized medicine. cln 

current position: Morris Herzstein Professor of Biology and Physiology, 

Department of Biochemistry and Biophysics, University of California, 

San Francisco; and Non-Resident Fellow, Salk Institute 

education: PhD, University of Cambridge, 1975 

previous positions: Department Chair, Department of Microbiology and 

Immunology at University of California, San Francisco (UCSF); Faculty 

Member, Department of Molecular Biology, University of California at 

Berkeley 

Blackburn was previously Chair of the 

Department of Microbiology and Immunology 

at the University of California 

San Francisco and is currently a faculty 

member in UCSF’s Department of Biochemistry 

and Physics. Prior to her work 

at UCSF, she was a faculty member in the 

Department of Molecular Biology at the 

University of California at Berkeley. She 

is also a Non-Resident Fellow of the Salk 

Institute. 

Blackburn is a member of the Institute 

of Medicine and is an elected Fellow of the 

American Academy of Arts and Sciences, 

the Royal Society of London, the American 

Academy of Microbiology, and the American 

Association for the Advancement of 

Science. She has served on Genetics Society 

of America board of directors and is a 

past president of the American Society for 

Cell Biology. Named California Scientist of 

the Year in 1999, Blackburn has received 

several prestigious awards, most recently 

the Dr. A. H. Heineken Prize for Medicine 

in 2004 and the 26th Annual Bristol-Myers 

Squibb Award for Distinguished Achievement 

in Cancer Research, among many 

others. She also shared the 2006 Lasker 

Award for Basic Medical Research for her 

work on telomerases. 

In her plenary lecture, Blackburn will 

discuss current findings about telomerase 

activity and its role in aging and cancers. 

She will explain the function of telomerase, 

correlate long and short telomere length to 

human diseases, and assess the evidence 

that supports the idea that telomerase is 

necessary for cell division. cln 

CliniCal laboratory news speCiaL eDiTion 3

INDUSTRY WORKSHOPS 

Tuesday, july 29 

7:00 a.m.–8:30 a.m. 

Abbott Diagnostics 

Six Sigma Quality and Process Improvement 

with Integrated Immunochemistry Systems 

Speakers: Sten Westgard, MS, Director of 

Client Services, Westgard QC, Inc. 

Rob Kerekes, Charge Technologist, 

Core Laboratory, MLT ART, Huron Perth 

Healthcare Alliance—Stratford Site 

Dave Armbruster, PhD, DABCC, FACB, 

Abbott Diagnostics, Global Scientific Affairs 

Manager 

Renaissance Hotel, Ballroom East 

Beckman Coulter, Inc. 

What is the Real Impact of WHO Standardization 

on PSA Results? 

Speakers: William J. Catalona, MD, 

Robert H. Lurie Comprehensive Cancer 

Center, Northwestern University 

Feinberg School of Medicine, 

Director, Clinical Prostate Cancer Program 

Kurtis R. Bray, PhD, Director, 

Clinical Research, Beckman Coulter, Inc. 

Grand Hyatt Washington, Constitution B 


Achieving the Next Level: Integrated Workcells 

Speakers: Monica Rassai, Marketing Manager, 

Chemistry Systems Business Center, 


Deborah L. Tennyson, Group Manager, 

Product Development Center, 


Renaissance Hotel, Grand Ballroom Central 

Bio-Rad Laboratories 

Implementation of Automated A1c Testing 

from Point-of-Care to On-Demand 

Automation 

Speakers: TBD 

Grand Hyatt Washington, Constitution E 

Biosite, Inc. 

Assessment of Critical Conditions: ACS and 

AKI- How Should We Approach Them? 

Speakers: Kent Lewandroski, Massachusetts 

General Hospital, Director of Clinical Services 

(Anatomic and Clinical) 

Kenneth E. Blick, PhD, University of 

Oklahoma Health Sciences Center and 

OU Medical Center, Director of Chemistry, 

Point of Care and Automation 

Angela StraLace, Medical Center of Arlington, 

Chief of Emergency Services 

Emil Paganini, Cleveland Clinic, Head, Section 

of Dialysis and Extracorporeal Therapy 

Renaissance Hotel, Grand Ballroom South 

DiaSorin 

The Emerging Impact of Vitamin D 

on Clinical Management of Disease 

Speakers: Reinhold Vieth, PhD, FCACB, 

Professor, Department of Nutritional Sciences, 

and Department of Laboratory Medicine and 

Pathobiology University of Toronto Director, 

Bone and Mineral Laboratory, Pathology and 

Laboratory Medicine, Mount Sinai Hospital 

Bruce W. Hollis, PhD, Professor of Pediatrics; 

Professor of Biochemistry and Molecular Biology; 

Director of Pediatric Nutritional Sciences; 

Darby Children’s Research Institute; Medical 

University of South Carolina 

Joan Lappe, PhD, RN, FAAN, Dr. CC & 

Mabel L Criss & Drs. Gilbert & Clinton Beirne 

Endowed Chair in Nursing & Professor of 

Medicine; Creighton University 

James Edward Dowd MD, FACR, Associate 

Clinical Professor of Medicine, Michigan State 

University; Michigan Arthritis Research Center 

Renaissance Hotel, Ballroom West A 

Nanogen 

CPOCT—in the ED and Alternate Sites: Are 

We Ready for It; Is It Ready for Us? 

Speakers: Kenneth E. Blick, PhD, Professor, 

Dept of Pathology, University of Oklahoma 

Health Sciences Center 

James L. Januzzi, MD, Associate Director, 

Coronary Care Unit, Associate Professor of 

More Great Learning Opportunities 

6 CliniCal laboratory news speCiaL eDiTion 

Medicine, Harvard Medical School, 

Massachusetts General Hospital 

Alan H.B. Wu, PhD, Chief, Clinical Chemistry 

and Toxicology Laboratories, 

San Francisco General Hospital, Professor, 

Dept of Lab Medicine, UC San Francisco 

Renaissance Hotel, Auditorium 

Ortho 

Changing the Paradigm of HIV Testing in the 

Hospital Setting With Rapid, Fully-Automated, 

Random Access HIV Testing 

Speakers: TBD 

Renaissance Hotel, Grand Ballroom North 

Psyche Systems Corporation 

Legacy System Connectivity and 

Compatibility with Emerging Technologies: 

How to Utilize Valuable Data While Leveraging 

Existing IT Infrastructure and Investment 

Speaker: Lisa-Jean Clifford, Psyche Systems 

Corporation, Senior Director Marketing & 

Business Development 

Grand Hyatt Washington, Constitution D & E 

Roche 

Got PCR? How to Start a 

Molecular Diagnostics Laboratory 

Speaker: Art Braden, PhD, Principle Applications 

Scientist, Medical & Scientific Affairs, 

Roche Diagnostics Corporation 

Grand Hyatt Washington, Independence E 

Roche 

Present on Admission? Understanding the 

Lab’s Role in Documenting Medical Severity 

and Contribution to Meeting the New CMS 

Quality Metrics 

Speaker: Dr. Robert S. Gold, DCBA, Inc., CEO 

Grand Hyatt Washington, Constitution A 

Roche 

Non-Compliance with Medication: 

Aiding the Clinician in Managing Patients by 

Providing Meaningful and Reliable Testing 

for Osteoporosis Therapies 

Speaker: Deborah T. Gold, PhD, 

Duke University Medical Sociology, 

Associate Professor of Medical Sociology 

Grand Hyatt, Independence G, H, I 

SeraCare Life Sciences 

Verifying and Evaluating Your Test Methods: 

It’s Not a Regulatory Exercise 

Speaker: Patricia E. Garrett, PhD, DABCC, 

SeraCare Life Sciences, Senior Director, 

Science and Technology 

Grand Hyatt, Independence D, E, F 

StanBio Laboratory 

Blood Ketones—Benefits Over Urine Testing 

and Future Applications 

Speaker: James H. Nichols, PhD, DABCC, 

FACB, Tufts University School of Medicine, 

Associate Professor of Pathology, 

Baystate Health System, Medical Director, 

Clinical Chemistry 

Grand Hyatt Washington, Independence B, C 

6:00 p.m.–7:30 p.m. 

Abbott Diagnostic 

Translational Medicine and the 

Clinical Laboratory—Emerging Biomarkers 

for Acute Kidney Injury 

Speakers: Chirag Parkh, MD, PhD, FACB, 

Yale University, Associate Professor of Medicine 

Prasad Devarajan, MD, University of 

Cincinnati College of Medicine, 

Cincinnati Children’s Hospital, Professor of 

Pediatrics and Development Biology 



Advances in the Fluorescent 

Analysis of Erythrocytes 

Speakers: Brice H. Davis, MD, President, 

Trillium Diagnostics, LLC., Bangor, ME 

Dr. Albert Huisman, Clinical Chemist, Utrecht 

Medical Center, Utrecht, The Netherlands 


Applied Biosystems 

Advances in the use of LC/MS/MS 

for the Analysis of Vitamin D, Steroids, 

and TDM Clinical Research 

Speakers: TBD 

Grand Hyatt, Independence G, H, I 

BD 

Improving Operational Efficiencies in the CT/ 

GC DNA Testing Laboratory: Implementing 

Lean Processes with the BD Viper System 

Speakers: Patrick Maul, Principle Consultant, 

BD Diagnostics-Healthcare Consulting 

David Chow, Microbiology and Parasitology 

Manager, BC Biomedical Laboratories 

Grand Hyatt Washington, Independence B, C 


Clinical Performance Comparison of 

Two Contemporary Cardiac Troponin Assays 

and the Uses of Highly Sensitive Troponin 

Assays in the Clinical Setting 

Speakers: Professor Pervenge, MD, PhD, 

University of Uppsala, Dept. of Clinical 

Chemistry and Pharmacology 

Alan S. Jaffe, MD, Professor of Medicine 

Mayo Medical School 



Explore How Instrument Productivity 

Can Be Improved and Uptime Increased 

Through Remote, Internet-Based 

Diagnostics and Monitoring 

Speakers: Stephen Ishii, Marketing Manager, 

Chemistry System Business Center, Beckman 

Coulter, Inc. 

Ian Burgess, Group Manager, Information 

Technology, Product Development Center, 


Jodey Workman, Staff Applications Scientist, 

Chemistry System Business Center, 


Grand Hyatt Washington, Independence D, E 


Performance of Manual Versus 

Lean Laboratory Automation 

Speaker: Dr. Ralph Dadoun, Vice President of 

Corporate Services, St. Mary’s Hospital Centre, 

Montreal 

Renaissance Hotel, Congressional Hall B 

DiaSorin 

The Emerging Clinical Impact of Vitamin D 

on Clinical Management of Disease 

Speakers: Reinhold Vieth, PhD, FCACB, 

Professor, Department of Nutritional Sciences, 

and Department of Laboratory Medicine and 

Pathobiology University of Toronto Director, 

Bone and Mineral Laboratory, Pathology and 

Laboratory Medicine, Mount Sinai Hospital 

Bruce W. Hollis, PhD, Professor of Pediatrics; 

Professor of Biochemistry and Molecular Biology; 

Director of Pediatric Nutritional Sciences; 

Darby Children’s Research Institute; 

Medical University of South Carolina 

Joan Lappe, PhD, RN, FAAN, Dr. CC & 

Mabel L Criss & Drs. Gilbert & Clinton Beirne 

Endowed Chair in Nursing & Professor of 

Medicine; Creighton University 

James Edward Dowd, MD, FACR, Associate 

Clinical Professor of Medicine, Michigan State 

University; Michigan Arthritis Research Center 

Renaissance Hotel, Ballroom West B 

Instrumentation Laboratory 

Effective Implementation and Management 

of a Point-of-Care Program 

Speakers: James O. Westgard, PhD, Professor, 

Pathology Dept. and Laboratory Medicine, 

University of Wisconsin 

Sharon L. Ehrmeyer, PhD, Professor, 

Pathology Dept. and Laboratory Medicine, 

University of Wisconsin 

John J. Ancy, MA, RRT, Senior Clinical 

Consultant, Instrumentation Laboratory 


Invetech 

If You Think You Know What a Customer 

Need Is, Think Again 

Speakers: Fred Davis, CEO, Invetech 

Tony Ulwick, Founder, Strategyn 

Renaissance Hotel, Auditorium 

Nanosphere, Inc. 

The Clinical Utility of a Highly Sensitive 

Cardiac Troponin Assay 

Speakers: W. Frank Peacock IV, MD, FACEP, 

Vice Chief of Emergency Medicine, 

Cleveland Clinic 

Fred S. Apple, PhD, Medical Director, Clinical 

Laboratories, Henepin County Medical Center 

Renaissance Hotel, Congressional Hall B 

Pall Life Sciences 

Optimizing Diagnostic Assay 

Development: Material Considerations 

for Optimal Performance 

Speakers: Gialina Fomovska, PhD, 

Senior Research Scientist, Pall Corporation 

Martin Smith, PhD, Technical Director 

Pall Corporation 

Grand Hyatt Washington, Constitution D 

Thermo Fisher Scientific 

Implementation of LC-MS in a 

Clinical or Toxicology Laboratory— 

Assay Specific Workflows 

Speakers: Dr. Neil Leaver, Consultant Head of 

the IMS, Harefield Hospital, UK 

Dr. Sihe Wang, Director, Section of Clinical 

Biochemistry, Cleveland Clinic 

Dr. Dennis Crouch, Director, R&D, Ameritox 

Grand Hyatt Washington, Constitution C 

Waters Corporation 

Ultra Performance Liquid Chromotogram 

and Tandem Mass Spectrometry for the Clinical 

Laboratory 

Speakers: TBD 

Grand Hyatt Washington, Constitution E 

Wednesday, july 30 

7:00 a.m.–8:30 a.m. 


Current Trends in Organ Transplantation 

and Improved Immunoassays for 

Therapeutic Drug Monitoring 

Speakers: Sudarshan Hebbar, MD, 

Abbott Diagnostics Medical Affairs 

P.Y. Wong, PhD, FCACB, Professor of 

Laboratory Medicine and Pathobiology, 

University of Toronto 

Daniel M. Levine, PhD, Vice President for 

Clinical Biochemistry, The Rogosin Institute 


BD 

Maximizing Efficiency and Workflow in the 

Laboratory Using Lean Sigma Principles 

Speakers: Patrick Maul, Principal Consultant, 

BD Diagnostics-Healthcare Consulting 

Dr. Ana Stankovic, World Wide Vice President, 

Medical and Scientific Affairs and Clinical 

Operations, BD Preanalytical Systems 

Grand Hyatt Washington, Independence C, D 


Anemia and Diagnostic Analysis— Finding 

Clues with New Biochemical Markers 

Speakers: Robert T. Means, Jr., MD, Professor 

(Hematology/Oncology Division) & Senior 

Associate Chair, Dept. of Internal Medicine, 

Interim Director, Markey Cancer Center, 

University of Kentucky 

Vernon Mustoe, PhD, Scientific Affairs 

Manager, Beckman Coulter, Inc. 



The Essential Role of Real Time 

Standardized Middleware Software 

in Total Laboratory Automation 

Speaker: Kenneth E. Blick, PhD, ACS, ABCC, 

FACB, Professor, Dept. of Pathology, 

University of Oklahoma Health Science Center 


See industry Workshops, continued on p. 47

Opponents Want More Data 

Warfarin debate, from page 1 

The debate format represents 

a new twist to the 

standard sypmposia presented 

at the AACC Annual 

Meeting. Everyone who 

attends the debate will get 

a chance to weigh in on the 

michael Hallworth issue, Hallworth said. The 

audience will vote both before and after the 

debate to determine if the speakers were 

able to sway any opinions. 

Proponents Emphasize Potential 

Shiew-Mei Huang, PhD, 

Deputy Director of FDA’s 

Office of Clinical Pharmacology, 

will propose a motion 

in favor of more wide- 

shiew-mei Huang 

spread testing, reflecting 

FDA’s stance on the issue. 

FDA’s label language, which indirectly suggests 

that physicians consider pharmacogenomic 

testing to determine initial warfarin 

dose, is based on data showing that doing 

so keeps warfarin patients’ INRs in an acceptable 

range of 2–3. In the absence of definitive 

data from randomized, controlled 

trials that look at harder clinical outcomes 

like excessive bleeding events, FDA and virtually 

all practitioners have used INR as a 

surrogate outcome, she explained. 

“Recent studies have showed poor patient 

outcomes that we need to improve 

upon,” Huang added, pointing to a 1,015patient 

study by a research team led by 

Brian Gage, MD, of Washington University 

in St. Louis. The investigators found that 

a dosing algorithm based on clinical factors 

explained 17–22% of dose variability, 

while another algorithm that incorporated 

information about CYP2C9 and VKO- 

RC1 explained 53–54% of dose variabil- 

8 CliniCal laboratory news speCiaL eDiTion 

mark linder 

ity (Clinical Pharmacology 

Therapeutics 2008 doi: 

10.38/clpt.2008.10). 

Huang also plans to 

discuss data that support 

expected cost effectiveness 

of widespread testing. One 

recent report estimates that 

formally integrating genetic tests into routine 

warfarin therapy could allow American 

warfarin users to avoid between 4,500 

and 22,000 serious bleeding events annually, 

she pointed out (Personalized Medicine 

2008; 5: 279–284). 

Meanwhile, various studies also show 

that particular variants of the CYP2C9 and 

VKORC1 genes affect clearance and dose 

requirements. “There’s a consistent relationship. 

Even the worst critics of the test 

acknowledge this consistent 

and known relationship,” 

added Mark Linder, 

PhD, who is also speaking 

in favor of more widespread 

testing. Linder is 

Amir Jaffer 

Associate Director, Chemistry 

and Toxicology and 

Associate Director of the Pharmacogenetics 

Diagnostic Laboratory at University of 

Louisville Hospital in Louisville, Ky. and 

Senior Vice President of PGXL Laboratories, 

a private company that provides warfarin 

testing services. 

Wanted: Harder Outcomes 

Noting that the expected benefits—improved 

patient safety in the form of fewer 

bleeding and clotting incidents—have been 

detailed in various reports, opponents to 

more widespread use of pharmacogenomic 

warfarin testing are waiting for hard 

evidence of these benefits. “There’s good 

evidence that two SNPs on CYP2C9 and 

several on VKORC1 affect warfarin metab- 

Third annual 

olympus partnership awards 

presentation 

Monday, july 28 

1:30 p.m.–2:30 p.m. 

ballroom abc of the 

Walter e. Washington convention center 

“How Healthy is the 

Healthcare Debate on the 

Campaign Trail and in the 

Halls of Congress?” 

Cokie Roberts, Political Analyst 

for ABC News and National 

Public Radio Senior News 

Analyst, will share her thoughts 

on this timely topic. 

Underwritten by a grant from Olympus America. 

paragon dx offers 

Warfarin Genotyping 

Whatever their stance on warfarin pharmacogenomic testing, visitors to 

the Paragon Dx booth (3729) in the exhibit hall may learn their CYP2C9 

and VKORC1 genotypes at no cost. While Paragon Dx recently received 

FDA clearance for its Rapid Genotyping kit , the company also markets 

ASR reagents for lab-developed tests and will be using them to genotype 

meeting attendees onsite. According to Paragon Dx CEO Michael 

Murphy, the company hopes to show lab directors that it’s possible to 

run these warfarin pharmacogenomic tests in a space as small as the 

company’s exhibit booth. While labs can genotype samples with Paragon 

Dx reagents in 60 minutes, company representatives at the meeting 

will be batching tests because they expect to do several hundred of 

them. 

olism. This we know well,” said Amir Jaffer, 

MD, Associate Professor of Medicine at the 

University of Miami’s Leonard M. Miller 

School of Medicine and Service Chief of 

Medicine at Miami Hospital. “What we 

don’t know well is if testing translates into 

evidence of improved clinical outcomes.” 

Jaffer is speaking in opposition to more 

widespread testing. 

Both Jaffer and Charles Eby, MD, Associate 

Professor in the Department of Pathology 

and Immunology at Washington 

University St. Louis School of Medicine, 

Mo., want to see data that show warfarin 

pharmacogenomic testing actually reduces 

incidence of bleeding and mortality. Eby, 

who will also speak against widespread 

testing, considers such evidence the only 

true measure of the tests’ worth. “Not a single 

study shows a clinical benefit to testing,” 

he pointed out. 

While Huang maintained that a greater 

percentage of time within the target therapeutic 

target range and fewer patients with 

INRs >4 are indeed clinical benefits, Eby 

noted that only two trials that have used 

therapeutic INR as endpoints were randomized 

controlled studies. Those two 

studies yielded conflicting results. The first 

involved 206 patients and did not achieve 

a reduction in out-of-range INRs (Circulation 

2007;116: 2563–2570), but the other, 

with 201 patients, found incorporating genetic 

information into a dosing algorithm 

increased patients’ time in a therapeutic 

INR range (Clinical Pharmacology & Therapeutics 

2008; 83: 460–470). However, these 

studies’ control arms employed different 

strategies for using genetic information for 

warfarin dosing, Eby noted. 

Other Considerations 

Data aside, Eby raised concerns about how 

labs should report genetic information and 

how clinicians would use it. “Genetic information 

by itself has minimal value unless 

you put it into a dosing algorithm someone 

can carry around in their head,” he explained, 

“So should we provide an interpretation 

by saying that a particular genotype 

is associated with a decreased dose? Should 

we provide an algorithm?” 

Whatever labs report to physicians, “it’s 

more than the usual accurate, precise results,” 

Eby noted. While most hospital labs 

have experience providing specific interpretive 

comments for for certain tests, like 

D-dimer, “we’ve never had to customize results 

for each patient,” he pointed out. Eby 

also worries about labs communicating 

genetic information to an audience much 

wider than the oncology subspecialties 

that now receive it. Lab staff may be talk- 

ing to clinicians who lack the education 

and judgment to take into consideration 

several other necessary factors— like age, 

body mass, sex, and use of other drugs— 

into dosing decisions, according to both 

Eby and Jaffer. 

Linder doesn’t share these fears. He 

thinks opponents of wider testing are applying 

a double standard to the issue. They 

are worried about physicians learning to 

use the test through a process of trial and 

error, Linder said, but such processes are 

inherent to the practice of medicine in 

general and INR—the current standard of 

care—in particular. “People are applying a 

new set of rules to this test,” he said. 

Jaffer also worries that genetic data 

would be foisted upon physicians who are 

unprepared to use it safely, responsibly, and 

soon enough to yield benefits. One of his 

concerns is that existing algorithms might 

be too complicated for most physicians to 

use in routine practice. “If we make dosing 

more difficult, physicians might not start 

therapy as soon. That would have a counter 

effect on how patients do,” he asserted. 

But complex algorithms are nothing 

new, according to Huang. “Physicians adjust 

dosage of drugs used in renal failure 

with algorithms that are far more complicated,” 

she maintained. 

Linder disagrees with Jaffer’s expectation 

that most physicians who prescribe 

warfarin will use the pharmacogenomic 

tests. “The test isn’t for all physicians, but 

only those who understand it. It’s available 

and useful now to those with specific 

knowledge about how to use and interpret 

it,” he explained. 

Will Huang, Eby, Linder, and Jaffer sway 

any opinions about warfarin pharmacogenomic 

testing? The best way for meeting 

attendees to find out is by attending what 

promises to be an exciting debate. cln 

Stop by the 

AACC Booth 

#3629 

for the latest 

information on all 

our educational 

programs.

The American Association for Clinical Chemistry 

extends its sincere gratitude to the following companies for their 

generous support through their contributions. 


n Hotel Keycards (selected hotels) 

n NACB Alvin Dubin Award 

n Registration Portfolios 

n SYCL Domestic Travel Grant (through 

a gift to AACC’s Van Slyke Foundation) 

ACON Laboratories 

n Exhibitor Lanyards 


n American Board of Clinical Chemistry 

Reception 

n TDM/Toxicology Division 

Saturday Symposium 

AutoGenomics 

n AACC’s Van Slyke Foundation 

Silent Auction/Reception 

Fundraiser Support 

BD Diagnostics— 

Preanalytical Systems 

n International Travel Fellowship Award 

n International Travel Grants (through 

a gift to AACC’s Van Slyke Foundation) 

Beckman Coulter, Inc 

n Award for Outstanding Contributions 

through Service to the Profession of 

Clinical Chemistry 

n International Travel Grant (through a 

gift to AACC’s Van Slyke Foundation) 

n Student Travel Grants (through a gift 

to AACC’s Van Slyke Foundation) 


Reception 

n Carl Jolliff Award for Lifetime 

Achievement in Clinical or 

Diagnostic Immunology 

n Garry Labbe Award for 

Contributions to Laboratory 

Assessment of Nutritional Status 

n Nutrition Division 


Bio-Rad Laboratories 


Reception 

IVD Technology Magazine 

n International Marketing Seminar 

Fluidigm 

n Notepads and Pens 

Diagnostica Stago, Inc 

n ClinPack Door Drop Bags (selected 

hotels) 

Fujirebio Diagnostics, Inc 

n Attendee Lanyards 

Gen-Probe, Inc. 

n Molecular Pathology Division Town 

Hall Meeting 

Genzyme 

n Student Poster Contest (through a 

gift to AACC’s Van Slyke Foundation) 

n Student Oral Presentation Contest 

(through a gift to AACC’s Van Slyke 

Foundation) 

ITC 

n CyberLink Email Stations 

LifeScan 

n Point-of-Care Coordinator 

of the Year Award 

Luminex Molecular 

Diagnostics 

n Molecular Pathology Division 

Townhall Meeting 

Nova Biomedical 


Reception 

Olympus America, Inc., 

Diagnostic Systems 


in a Selected Area of Research 

n International Travel Grants 

(through a gift to AACC’s Van Slyke 

Foundation) 

n Exhibit Hall Lounge Beverage Breaks 

n Lead Retrieval Cards 

Osmetech 


Hall Meeting 

Ortho Clinical Diagnostics 

n Program and Exhibit Guides 

n Award for Outstanding Clinical 

Laboratory Contributions to 

Improving Patient Safety 

Perkin Elmer 

n AACC’s Van Slyke Foundation 

Silent Auction/Reception 

Fundraiser Support 

Promega 


Hall Meeting 

Quest Diagnostics 

Hospital Services 


in Education 

Roche Diagnostics 

n Award for Outstanding 

Scientific Achievements 

by a Young Investigator 


Reception 


Town Hall Meeting 

Siemens Healthcare 

Diagnostics 

n AACC Lectureship Award 

n Outstanding Lifetime Achievement 

Award in Clinical Chemistry and 

Laboratory Medicine 

n The Morton K. Schwartz Award for 

Significant Contributions in Clinical 

Chemistry 

n Award for Outstanding Contribution 

for a Publication in the International 

Journal, Clinical Chemistry 

n The Edwin I. Ullman Award 

n Aisle Banner Signage 

n NACB Distinguished Scientist Award 

n Clinical & Diagnostic Immunology 

Division Issues in Immunodiagnostics 

Symposium 


Reception 

Suntec Medical, Inc. 

n Young Investigator Award for 

Outstanding Research in Molecular 

Pathology or Pharmacogenomics 




Utak Laboratories, Inc. 

n Utak Young Investigator Award in 

Therapeutic Drug Management 

and Toxicology 

Waters Corporation 


Town Hall Meeting 



CliniCal laboratory news Special edition 9

2008 AACC AwA r d wi n n e r s 

Clinical Laboratory Science Leaders Receive Awards 

At the opening plenary session of the 2008 Annual Meeting, a dozen leaders in the field of clinical laboratory medicine were 

recognized for their outstanding contributions. AACC President Larry A. Broussard, PhD, DABCC, FACB, and representatives of the 

sponsoring companies presented the awards. AACC and CLN are proud to note a few of their many accomplishments below. 

The AACC Lectureship Award 

Sponsored by an educational grant from 

Siemens Healthcare Diagnostics 

P. Roy Vagelos, MD 

Dr. Vagelos is retired chairman 

and CEO of Merck 

& Co. He served as senior 

surgeon and section head 

of comparative biochemistry 

at the National Institutes 

of Health for a decade. In 1966, he 

became chair of the department of biological 

chemistry at the Washington University 

School of Medicine in St. Louis and in 1973 

founded the university’s division of biology 

and biomedical sciences. He joined Merck 

in 1975 as senior vice president for research 

and became president of its research division 

in 1976. In 1985, he became CEO, a 

post from which he retired in 1994. Before 

assuming broader responsibilities of business 

leadership, Dr. Vagelos had won scientific 

recognition as an authority on lipids 

and enzymes and as a research manager. 

The author of more than 100 scientific 

papers, he received the Enzyme Chemistry 

Award of the American Chemical Society 

in 1976. He is a member of the National 

Academy of Sciences, the American Academy 

of Arts and Sciences, and the American 

Philosophical Society. He has received 

14 honorary doctorates, and his many 

awards in science and business include the 

Lawrence A. Wien Prize in Social Responsibility 

from Columbia University and the 

National Academy of Sciences Award for 

Chemistry in Service to Society. He served 

as chairman of the board of the University 

of Pennsylvania and chairs the board of 

visitors at Columbia University Medical 

Center. He is currently chair of Regeneron 

Pharmaceuticals and Theravance, two biotech 

companies. 

Outstanding Lifetime Achievement Award in 

Clinical Chemistry and Laboratory Medicine 

Sponsored by Siemens Healthcare Diagnostics 

Mary F. Burritt, PhD, FACB, HCLD 

(ABB) 

Dr. Burritt is professor of 

laboratory medicine at 

the Mayo Clinic College 

of Medicine and clinical 

chemist at Mayo Clinic 

Arizona in Scottsdale. She 

previously held the positions of medical 

co-director of the Central Clinical Laboratory 

and director of the Metals Laboratory 

at the Mayo Clinic as well as associate dean 

of the Mayo School of Health Sciences in 

Rochester, Minn. Dr. Burritt has served 

AACC in many roles over the past 30 years, 

including president in 1996 and chair of 

the annual meeting organizing committee 

in 2000. Dr. Burritt has been active in the 

Clinical and Laboratory Standards Insti- 

10 CliniCal laboratory news Special edition 

tute, serving as chair of the Subcommittee 

on Electrolytes, as chair of the Area Committee 

on Clinical Chemistry for 5 years, 

and as a member of the Volunteer Resources/Program 

Committee. She has also been 

active on the international level, serving as 

the vice chair of the Education and Management 

Division and chair of the visiting 

lecturer program of the International 

Federation for Clinical Chemistry and 

Laboratory Medicine (IFCC) for 6 years 

in each position. Among her contributions 

in education and research, she directed the 

postdoctoral training program in clinical 

chemistry at the Mayo Clinic for 8 years. 

She has lectured extensively both nationally 

and internationally on many topics 

including technical and clinical aspects of 

ionized calcium, POCT, quality systems, 

and automation. Dr. Burritt has published 

more than 195 peer-reviewed articles, abstracts, 

and chapters. 

The Morton K. Schwartz Award for Significant 

Contributions in Cancer Research Diagnostics 


Martin Fleisher, PhD, FACB 

Dr. Fleisher is chair of the 

department of clinical 

laboratories and director 

of the clinical chemistry 

laboratory at the Memorial 

Sloan-Kettering Cancer 

Center in New York City. Dr. Fleisher joined 

the medical staff at Memorial Sloan-Kettering 

as an assistant attending biochemist 

and spent 35 years working closely with the 

award’s namesake, Dr. Morton K. Schwartz, 

then chair of the department of biochemistry. 

Dr. Fleisher has spent his career in 

the study, discovery, and development of 

tumor markers and biomarkers in cancer 

detection. His interest in biomarkers began 

in 1970 with the validation of carcinoembryonic 

antigen in colon cancer. His seminal 

work on the relationship between breast 

cancer and cystic mastopathy involved 

more than 1,000 women, whose breast cyst 

fluids were analyzed for more than 80 analytes. 

He investigated the use of biomarkers 

in node-negative women with breast cancer 

and developed methods to monitor therapy 

that are still in use at many medical centers. 

In collaboration with his neuro-oncology 

colleagues, he developed cerebrospinal fluid 

tumor markers. Dr. Fleisher’s current research 

focuses on the use of biomarkers for 

new targeted preclinical and clinical drug 

development and the identification of gene 

expression patterns in cancer metastasis. 

An active member of AACC since 1968, Dr. 

Fleisher has served as national treasurer, a 

member of the board of directors, co-chair 

of the 1993 annual meeting, and in many 

other positions. He is a member of the 

board of directors of the National Academy 

of Clinical Biochemistry and president of 

the Clinical Ligand Assay Society. 

Award for Outstanding 

Contributions in Education 

Sponsored by Quest Diagnostics Nichols Institute 

William E. Winter, MD, DABCC, 

FACB 

Dr. Winter is a professor 

in the departments of pathology, 

immunology, and 

laboratory medicine; pediatrics; 

and molecular genetics 

and microbiology at 

the University of Florida College of Medicine 

in Gainesville. Dr. Winter directed the 

pathology residency training program at 

the University of Florida for 10 years before 

being appointed as course director for 

the second year medical student pathology 

course in 2004. He has given numerous 

presentations and has published extensively 

on behalf of AACC. With Dr. M. 

Signorino, he authored AACC’s monograph, 

Diabetes Mellitus. With Drs. I. Jialal 

and D. Chan, he co-authored AACC’s 

Handbook of Diagnostic Endocrinology. A 

five-time winner of the AACC Outstanding 

Speaker Award, Dr. Winter served on the 

AACC Annual Meeting Organizing Committee 

in 1998 and 2003 and is presently on 

the 2009 committee. He chaired the organizing 

committee for AACC’s professional 

practice in clinical chemistry course in 2005 

and 2007 and chairs the 2009 course. He is 

a fellow of the National Academy of Clinical 

Biochemistry and the College of American 

Pathologists. He is currently a member 

of the board of directors of the National 

Academy of Clinical Biochemistry. Including 

articles, chapters, and abstracts, he has 

contributed nearly 200 publications that 

deal with chemistry, coagulation, diabetes, 

endocrinology, and immunology. 

Award for Outstanding Contributions 

In a Selected Area of Research 

Sponsored by Olympus America Inc., 

Diagnostic Systems 

Marilyn A. Huestis, PhD 

Dr. Huestis is a tenured 

senior investigator and the 

chief of the chemistry and 

drug metabolism section 

of the clinical pharmacology 

and therapeutics 

research branch at the NIDA in Bethesda, 

Md. She holds an adjunct associate professor 

appointment at the University of 

Maryland in Baltimore. She directs a large 

research program that seeks to discover the 

mechanisms of action of cannabinoid agonists 

and antagonists, the effects of in utero 

drug exposure, and the neurobiology and 

pharmacokinetics of MDMA (ecstasy). Dr. 

Huestis currently is the principal investigator 

of a phase I clinical study evaluating 

cognitive performance and related brain 

activation of acute and chronic cannabis 

exposure using functional magnetic resonance 

imaging. The study also investigates 

and contrasts spontaneous and antagonistelicited 

cannabis withdrawal. Dr. Huestis 

was director of one of the first forensic 

urine drug testing laboratories among 150 

applicants to be certified by NIDA. She 

serves on the World Anti-doping Agency’s 

Prohibited List Committee and the U.S. 

Anti-Doping Agency’s Research Advisory 

Panel. Dr. Huestis is past president of the 

Society of Forensic Toxicologists, past chair 

of the Toxicology Section of the American 

Academy of Forensic Sciences, and the first 

woman president of the International Association 

of Forensic Toxicologists. She has 

published 145 peer-reviewed manuscripts, 

published numerous book chapters and 

monographs, and presented more than 

220 abstracts at national and international 

meetings. 

Award for Outstanding Clinical Laboratory 

Contributions to Improving Patient Safety 

Sponsored by Ortho Clinical Diagnostics 

Mario Plebani, MD, FACB 

Dr. Plebani is full professor 

of clinical chemistry and 

clinical molecular biology 

at the University of Padova 

School of Medicine, chief 

of the department of laboratory 

medicine at the University Hospital 

of Padova, chief of the Center of Biomedical 

Research (a specialized center for quality 

in laboratory medicine for the Veneto 

Region), and scientific coordinator of the 

regional anti-doping laboratory at the University 

Hospital in Padova, Italy. He served 

as president of the International Society of 

Enzymology for 5 years and of the Italian 

Society of Clinical Biochemistry and Molecular 

Clinical Biology for 4 years. He currently 

serves on the AACC Patient Safety 

Advisory Group and the International Advisory 

Group. Dr. Plebani is reviews editor 

of Clinical Chemistry and Laboratory Medicine, 

associate editor of Clinical Biochemistry, 

CRC Clinical Laboratory Sciences, and 

International Journal of Biological Markers 

and editor-in-chief of a journal on clinical 

governance. His main areas of research are 

quality in laboratory medicine, biomarkers 

in cancer and cardiovascular diseases, 

and in vitro allergy diagnostics. He has 

published 560 original papers, including a 

widely cited paper in Clinical Chemistry in 

1997 dealing with errors in a stat laboratory 

that received great acceptance. In 2007 he 

published a new paper in the same journal 

describing the laboratory errors situation 

after 10 years. He is guest editor of a special 

issue of Clinical Chemistry and Laboratory 

Medicine dedicated to “Laboratory 

Medicine and Patient Safety” and author 

of many papers on the topic of laboratory 

errors and patient safety. 

AACC Awards, continued on page 12

AACC Awards, from page 10 


Through Service to the Profession 

Sponsored by Beckman Coulter, Inc. 

Susan A. Evans, PhD, FACB 

Dr. Evans is vice president 

and general manager of 

Agencourt Bioscience, a 

Beckman Coulter Company 

in Beverly, Mass., that 

provides genomic services 

and nucleic acid purification products for 

clinical and life science researchers. She 

has more than 25 years of experience in 

the diagnostic industry, holding leadership 

positions in research and development and 

now general management. She has developed 

assays for analytes in the areas of endocrinology, 

fertility, cardiac markers, and 

TDM. Dr. Evans’s involvement with AACC 

began in the 1980s, when she served as an 

officer in the Florida Section and continued 

with local section activities in San Diego 

and Chicago. Her service to AACC on 

the national level includes being elected to 

the board of directors, as national secretary, 

and as president in 2003. She chaired the 

Program Coordinating Commission twice, 

was one of the founding members of the 

Industry Division, and is vice chair of the 

2008 Annual Meeting Organizing Committee. 

She currently serves as president 

of the National Academy of Clinical Biochemistry, 

where she has also served on the 

board of directors. Dr. Evans has also volunteered 

her time to the IFCC, including 

as secretary and corporate representative to 

its Education and Management Division, 

and to the Clinical Laboratory Standards 

Institute through membership on several 

committees. 

Award for Outstanding Scientific 

Achievements by a Young Investigator 

Sponsored by Roche Diagnostics 

Alex J. Rai, PhD, DABCC, FACB 

Dr. Rai is an assistant attending 

clinical chemist 

in the clinical chemistry 

service of the department 

of pathology at Memorial 

Sloan-Kettering Can- 


cer Center in New York City. During his 

fellowship training at the Johns Hopkins 

University School of Medicine, Dr. Rai 

focused on proteomics- and bioinformatics-based 

biomarker discovery in ovarian 

cancer, in addition to his clinical service 

training. His current research interests lie 

in the discovery of novel biomarkers for 

cancer and their translation into clinically 

useful diagnostic tests. Recent projects 

have included biomarker discovery using 

multiplexed gene expression profiling and 

proteomics techniques, and development 

of assays for multiplexed single nucleotide 

polymorphism analysis. He is interested in 

designing, evaluating, and validating tests 

for stratifying cancer subtypes and identifying 

patients unable to metabolize chemotherapeutic 

drugs. By stratifying a patient’s 

disease based on biomarker profiles and 

screening patient genotypes prior to their 

starting therapy, treatment of a patient’s 

cancer and selection of the most appropriate 

therapeutic regimen can be tailored. 

Dr. Rai has published more than 20 scientific 

articles and presented more than 25 

invited lectures nationally and internationally. 

He serves on committees for several 

professional organizations, including the 

New York Metro Section of AACC, the National 

Academy of Clinical Biochemistry, 

and the Clinical Ligand Assay Society. 

International Travel Fellowship 

Sponsored by BD Diagnostics— 

Preanalytical Systems 

Renze Bais, PhD 

Dr. Bais is chief operating 

officer of Pacific Laboratory 

Medicine Services and 

clinical senior lecturer in 

the department of medicine 

at the University of 

Sydney. He is also an associate of the Royal 

College of Pathologists of Australasia. He 

has been involved in research and development 

in a variety of areas and published 

more than 90 scientific papers and book 

chapters and over 100 abstracts of presentations 

at both national and international 

meetings. He recently co-authored 

two chapters on enzymology for the Tietz 

Textbook of Clinical Chemistry and for Fundamentals 

of Clinical Chemistry. He has 

been active with the IFCC for many years, 

Genzyme Student Oral 

Presentations and Poster Contest 

Monday, July 28 

2:00 p.m.–4:30 p.m. 

Renaissance Washington, D.C. Hotel 

Congressional Hall B and C 

This symposium, which highlights research by students, offers presentations 

of student abstracts in both oral and poster formats. The first hour 

consists of oral presentations from the four students who received the 

highest scores in the preliminary judging phase of the contest, and the 

remainder of the afternoon consists of students competing in the poster 

contest. Students will compete for cash awards as they are judged on 

scientific content, originality, and presentation style. These events provide 

an inspiring glimpse of the future leaders in laboratory medicine. 

This program is funded by a generous gift provided by 

Genzyme Corporation to the Van Slyke Foundation. 

including 6 years as a member of Scientific 

Division Executive committee and 5 years 

as a member of the executive board and 

federation secretary. Dr. Bais has held various 

positions within the Australasian Association 

of Clinical Biochemists, including 

chair of both the South Australian and 

New South Wales Branches, vice president, 

and chair of the Scientific and Regulatory 

Affairs Committee. For the past 5 years, 

Dr. Bais has been the Australian coordinator 

of the Australasian Association of 

Clinical Biochemists/Vietnamese Association 

of Clinical Biochemistry joint project 

on quality assurance. This project aims to 

develop quality systems for Vietnamese 

laboratories and to set up quality assurance 

programs in Vietnam. He plans to use 

this International Travel Fellowship award 

to further the development of quality systems 

and assurance programs in Southeast 

Asian countries. 

The Edwin F. Ullman Award 


John F. Burd, PhD 

Dr. Burd is a co-founder 

and general partner of 

Sabur Technology in San 

Diego, Calif., a company 

dedicated to developing 

unique medical testing 

products. Previously, he was founder and 

CEO of Oculir, Inc., which developed a remarkable 

new non-invasive analyte testing 

technology. Dr. Burd has been a leader in a 

large number of companies involved in developing 

medical devices. He was a general 

partner of Windamere Venture Partners, 

a firm that started more than 15 medical 

product and biotechnology companies 

during his tenure. He was CEO of Mira- 

Medica, a company developing computeraided 

detection technology for enhanced 

cancer diagnosis that was sold to Kodak in 

August 2003. As president and CEO of Dex- 

Com, he directed the company’s work to 

develop, manufacture, and market the first 

long-term implantable glucose sensor. He 

was the founder of LXN Corp., which developed 

the Duet Diabetes Control System 

and the In Charge Diabetes Control System. 

LXN was sold to Johnson and Johnson in 

2000. At Quidel Corp., he directed the development 

of enzyme immunoassay products 

for the clinical laboratory, physician’s 

office, and home markets. As executive vice 

president of Mast Immunosystems, his responsibilities 

included research and development, 

marketing, sales, and finance. Dr. 

Burd began his career developing fluorescent 

immunoassays and performing medical 

product research and development at 

Miles Laboratories. Dr. Burd has authored 

and co-authored numerous articles and his 

work has led to 25 patents and the development 

of many innovative products. 

The AACC Past President’s Award 

Gary L. Myers, PhD, FACB 

Dr. Myers is chief of the 

clinical chemistry branch 

at the Centers for Disease 

Control and Prevention 

(CDC) in Atlanta, Ga. He 

also serves as the scientific 

director of the World Health Organization 

Collaborating Center for Reference and 

Research in Blood Lipids at the CDC. His 

30-year career at the CDC has focused on 

improving the laboratory measurement of 

biochemical markers used to assess chronic 

disease risk, particularly cardiovascular 

disease. Dr. Myers has served AACC at all 

levels, including chair of the Lipids and Lipoproteins 

Division, 2002 Annual Meeting 

Organizing Committee, and 2006 Beckman 

Conference. He has served on the 

Meetings Management Group, Nominating 

Committee, and Board of Directors. 

Under his leadership, 2007 was an exciting 

and busy year for AACC as it made progress 

in all of its strategic initiatives. It was 

also a transitional year, as Dr. Myers directed 

the search for a new editor-in-chief for 

AACC’s flagship journal, Clinical Chemistry. 

It was a special year for the Web site Lab 

Tests Online, which expanded into six new 

countries, including Australia, Germany, 

Hungary, Italy, Poland, and Spain. Lab Tests 

Online is recognized as the premier online 

source for information about laboratory 

testing. The Personalized Medicine Advisory 

Group was formed to recommend how 

AACC should embrace and become active 

in this rapidly expanding area. Another 

important initiative was partnering with 

the Association for Molecular Pathology 

to develop and offer a molecular pathology 

review course in 2008. 

Award for Outstanding Contribution 

For a Publication in the International 

Journal Clinical Chemistry 


Hassan Dihazi, PhD 

Dr. Dihazi is associate professor, 

group leader of proteomics 

in the department 

of nephrology and rheumatology, 

and director 

of the clinical proteomics 

facility at the Georg-August University in 

Göttingen, Germany. His research focuses 

on key proteins connecting cellular stress response 

pathways to renal diseases. His group 

also seeks to develop new clinical proteomics 

approaches for earlier diagnosis of human 

diseases and biomarker discovery. Dr. 

Dihazi is a council member of the Human 

Kidney and Urine Proteomics Project and 

the European Kidney and Urine Proteomics 

Association. He is also the co-founder of the 

Göttingen Proteomics Forum. He is involved 

in several proteomics journals as an editorial 

board member and is editor-in-chief 

of Proteomics Insights. He has published a 

number of articles on proteomics, especially 

their relation to kidney function. In his winning 

article, “Characterization of diabetic 

nephropathy by urinary proteomic analysis: 

identification of a processed ubiquitin form 

as differentially excreted protein in diabetic 

nephropathy patients,” Dr. Dihazi described 

a robust procedure for the identification and 

characterization of proteins differentially excreted 

in the urine of diabetic patients with 

microalbuminuria and/or macroalbuminuria. 

He also identified indicators of tissue 

injury in urine that may result in clinical 

applications for early diagnosis of diabetes 

mellitus-related nephropathy. The paper’s 

co-authors were Gerhard A. Mueller, Sandra 

Lindner, Markus Meyer, Abdul R. Asif, 

Michael Oellerich, and Frank Strutz (Clin 

Chem 2007; 53:9, 1636–1645).

NACB 2008 Award Winners 

Through its annual awards program, NACB, the Academy of AACC, celebrates the achievements of colleagues who have made significant 

contributions through scholarship and service to the profession. Chaired by Dr. Elizabeth Frank, the NACB Awards Committee wishes to 

thank the sponsors of these awards and to congratulate the 2008 award winners. 

DISTINGUISHED SCIENTIST AWARD 

For Outstanding Research Advances in 

the Field of Clinical Biochemistry 

Sponsored by Siemens Healthcare Diagnostics, 

Inc. 

Gerald R. Cooper, MD, PhD, DABCC, 

FACB 

Gerald R. Cooper, MD, PhD, 

has made AACC and NACB 

his professional home. In 

1952, he joined the Communicable 

Disease Center 

(CDC) to establish a 

chemistry laboratory. In 1954, he received 

the American Medical Association Hektoen 

Award for his methodology research 

on paper electrophoresis. In 1955, he coauthored 

a paper published in the first issue 

of the journal Clinical Chemistry. In 

1956, Dr. Cooper was appointed Chief, 

CDC Chemistry, Hematology and Pathology 

Laboratories. 

In 1978, Dr. Cooper transferred to a Research 

Medical Officer appointment in the 

CDC Clinical Chemistry Branch, where he 

participated in cardiovascular disease services 

and research, mainly on cholesterol 

and lipoprotein biomarker risk factors. He 

was chair of the outstanding AACC Cholesterol 

Reference Method Study that led 

the way for CDC to develop a chemical 

cholesterol reference method and for NIST 

to develop a definitive cholesterol reference 

mass spectrometry method. Dr. Cooper directed 

the central laboratory for the NHLBI 

Coronary Drug Project for 52 cardiovascular 

clinics and was responsible for the 

laboratory standardization of more than 30 

clinical trials, including the NHLBI Lipid 

Research Clinics trial and Multiple Risk 

Factor Intervention Trial. He continues today 

to serve as Research Medical Officer for 

the Clinical Chemistry Branch and Medical 

Director of the WHO Collaborating Center 

for Reference and Research in Blood Lipids 

established at CDC. 

GEORGE GRANNIS AWARD 

For Excellence in Research 

and Scientific Publication 

Sponsored by NACB with support from the 

AACC Ohio Valley Section 

Amy K. Saenger, PhD 

Amy K. Saenger received 

her PhD in chemistry from 

the University of Minnesota 

in 2004. For her thesis, she 

studied human mutations 

in the short-chain acyl-CoA 

dehydrogenase enzymes. After completing 

her graduate studies, Dr. Saenger joined the 

Clinical Chemistry Fellowship Program 

at the University of Washington in Seattle. 

Here, she expanded her research interests 

to include novel risk markers for oxidative 

stress and development of new testing using 

LC-MS/MS. In 2006, Dr. Saenger joined 

the staff at the Mayo Clinic as the Director 

of the Central Clinical Laboratory and 

Central Processing and Assistant Professor 

of Laboratory Medicine within the College 

of Medicine. Her current research interests 

include novel biomarkers for detection of 

oxidative and cardiovascular stress, dam- 

age, and heart failure. 

Dr. Saenger has been the recipient 

of several honors and awards, including 

grants from the American Heart Association 

in 1997, and pre-doctoral grants 

from the NIH (2000–2003). She has been 

honored twice with the Paul E. Strandjord 

Young Investigator Award from the Academy 

of Clinical Physicians and Scientists in 

2005 and 2006 and the Strandjord/Clayson 

Award for Meritorious Research from the 

University of Washington, Department of 

Laboratory Medicine in 2006. 

ALVIN DUBIN AWARD 

For Outstanding Contributions to the 

Profession and the Academy 

Sponsored by Abbott Diagnostics 

Ronald J. Whitley, PhD, DABCC, 

FACB 

Ronald Whitley, PhD, is 

Professor, Department of 

Pathology and Director, 

Clinical Chemistry and 

Core Laboratories, University 

of Kentucky. He 

received his BS degree in chemistry from 

Georgia Tech. He attended graduate 

school in biochemistry at Emory University 

and returned to Georgia Tech to earn 

his PhD in organic chemistry (1975). After 

completing a 3-year NIH postdoctoral 

fellowship in endocrinology at the Mayo 

Clinic, he remained in Rochester and 

trained for an additional 2 years in clinical 

chemistry. 

Dr. Whitley joined the faculty of the 

NACB Congratulates the 

2008 Distinguished Abstract Award Recipients 

University of Kentucky in 1980. He oversees 

dozens of laboratory procedures and is 

responsible for validation of new tests, instruments 

and technologies in the core laboratory, 

special chemistry, and POCT services. 

He also helps assess the significance 

of unusual test results, directs a chemistry 

training program for pathology residents, 

and participates in clinical conferences 

and didactic teaching sessions with medical 

students, pediatric residents, endocrine 

fellows, and medical technology graduate 

students. 

His scientific interests include applications 

of immunoassays and mass spectometry 

to endocrine and genetic disorders. He 

authored or co-authored the general endocrine, 

thyroid, adrenal and catecholamine 

chapters in the Tietz Textbook of Clinical 

Chemistry, 3rd edition, and authored the 

endocrine and amino acids sections in the 

Clinical Guide to Laboratory Tests, 2nd and 

3rd editions. He has helped developed consensus-based 

guidelines for using tumor 

markers in thyroid cancer and for follow-up 

testing of metabolic diseases identified by 

expanded newborn screening. He has also 

helped develop CLSI consensus documents 

for immunoassay systems and newborn 

screening blood collections. 

Dr. Whitley is a Diplomate of the 

American Board of Clinical Chemistry, an 

active member of AACC, and a fellow of 

NACB. He currently serves as a member 

of the NACB Expanded Newborn Screening 

Guidelines Committee. He has served 

AACC and NACB in a variety of leadership 

roles. 

A panel of NACB Fellows selected the following 26 abstracts as representing scientific excellence worthy of special recognition from the 725 

accepted abstracts. Look for the NACB blue ribbon on these distinguished abstracts in the poster sessions. 

Tuesday, July 29, 10:00 a.m. Qing H. Meng (B-65) 

John Ferrara (A-97) 

The role of procalcitonin in the diagnosis 

of sepsis and patient assignment to 

medical intensive care. 

Amy Mondelblatt (A-99) 

Traditional igh-esolution CSF protein 

electrophoresis is ineffective in detecting 

oligoclonal banding. 

Qing H Meng (A-113) 

Transforming growth factor-ß1 is a 

potential marker for kidney damage in 

patients with essential hypertension: 

renoprotective effect of ACE inhibitor 

and/or angiotensin II receptor blocker. 

Paul R Desjardins (A-120) 

Comparing the clinical effectiveness of 

fetal fibronectin and IGFBP-1 measurements 

in cervico-vaginal secretions, in 

predicting preterm deliveries. 

Tuesday, July 29, 2:00 p.m. 

Beneficial effects of soy isoflavones on 

insulin secretion, glucose control, and 

cataract prevention in streptozotocininduced 

diabetic rats. 

Larry H. Bernstein (B-80) 

Correcting NT-ProBNP level for effect of 

renal function impairment. 

Pete Kavsak (B-134) 

Preliminary investigation of a high 

sensitivity PAPP-A research assay in an 

Acute Coronary Syndrome population. 

Alexander Semenov (B-141) 

The difference in glycosylation between 

human proBNP and NT-proBNP suggests 

a new regulatory level in proBNP 

processing. 

Paul O. Collinson (B-146) 

The second international collaborative 

study of N-terminal pro B type natriuretic 

peptide (NTproBNP) in primary 

care (ICON II-PC). 

Lorin M. Bachmann (B-27) 

A novel proteomics platform for LCtandem 

MS-based quantification of 

differentially expressed proteins in 

complex biofluids. 

Amy K. Saenger (B-153) 

Modulation and relationship of brain 

natriuretic peptides to estrogen and 

androgens, as investigated in a pediatric 

population. 

John R. Petersen (B-41) 

Jordi Ordonez-Llanos (B-157) 

Evaluation of the APRI (AST, platelet A formula combining ST2 and NT- 

ratio index) and ELF (Enhanced Liver proBNP enhances prognostic accuracy 

Fibrosis) tests to detect significant 

14 CliniCal laboratory news Special edition in patients with heart failure. 

fibrosis due to chronic hepatitis C. 

Wednesday, July 30, 10:00 a.m. 

Naohito Ishii (C-10) 

Hemodialysis suppresses nitrotyrosine 

residue formation in patients with 

diabetes mellitus. 

Zhimin Cao (C-42) 

Poor interlaboratory agreement of 

testosterone measurements using 

HPLC-tandem mass spectrometry. 

Jagadish Ulloor (C-70) 

Dynamics of testosterone and SHBG 

interaction. 

Wednesday, July 30, 2:00 p.m. 

Johan Frostegård (D-29) 

Low levels of antibodies against phosphorylcholine 

predict development of 

atherosclerosis. 

Amar A Sethi (D-32) 

Pre-beta HDL is a strong positive diagnostic 

risk marker for ischemic heart 

disease in subjects with both high and 

low HDL-C levels. The Copenhagen City 

Heart Study. 

Werner Steimer (D-52) 

Influence of Cyp1A2*1F polymorphism 

on olanzapine serum concentrations 

and clinical outcome. 

Werner Steimer (D-54) 

Influence of Cyp2C19 polymorphisms 

on citalopram serum concentrations 

and clinical outcome. 

Kristen K. Reynolds (D-70) 

Accuracy of genotype-based 

warfarin dose estimation and plasma 

S-warfarin pharmacokinetic modeling. 

Alexander Haliassos (D-104) 

Early markers of acute kidney injury in 

ICU multitrauma patients. Preliminary 

report. 

Michael I. Watkins (D-147) 

Hemolysis interference does not equal 

hemoglobin interference; Non-hemoglobin 

interference by the hemolysate 

of red blood cells (RBC). 

Thursday, July 31, 10:00 a.m. 

Mark A. Cervinski (E-10) 

Qualitative point-of-care (POC) and 

over-the-counter (OTC) urine hCG 

devices detect various isoforms of hCG 

during early pregnancy. 

Soumaya El Rouby (E-22) 

Monitoring heparin therapy during 

cardiopulmonary bypass and cardiac 

interventional catheterization in pediatrics. 

Shu-Ling Liang (E-95) 

Falsely-elevated acetaminophen results 

in icteric and hemolyzed specimens.

Divisions Recognize Contributions to Laboratory Medicine 

AACC’s divisions recognize the achievements and contributions of their colleagues through awards and travel grants. 

The divisions offer congratulations to the following 2008 award winners: 

AnimAl CliniCAl Chemistry Division 


to Animal Clinical Chemistry 


N. Leigh Anderson, PhD, CEO, Plasma 

Proteome Institute, Washington, DC 

Outstanding Research in Animal 

Clinical Laboratory Medicine 

To be announced. 

CliniCAl & DiAgnostiC immunology Division 

International Travel Grant 

Adelani Adebisi, FMCPath, University of 

Ilorin, Nigeria 

Carl Jolliff Award for Lifetime 

Achievement in Clinical or 

Diagnostic Immunology 

Ishwarlal Jialal, MD, PhD, UC Davis 

Medical Center, Sacramento, Calif. 

Outstanding Research in Clinical 

and Diagnostic Immunology 

Lei Zhu, University of Helsinki, 

Helsinki, Finland 

Detecting PSA-API Based on Proximity 

Ligation Assay 

CritiCAl AnD Point-0f-CAre testing Division 

Point-of-Care Coordinator of the Year 

Peggy Mann, University of Texas Medical 

Branch, Texas City, Texas 

Outstanding Research in Critical Care 

or Point-of-Care Testing 

Soumaya El Rouby, PhD, ITC, 

Piscatawa, NJ 

Monitoring Heparin Therapy during 

Cardiopulmonary Bypass and Cardiac 

Interventional Catheterization in Pediatrics 

Research Grant Recipient 

Dr. Subir Kumar Das, Amrita Institute of 

Medical Sciences, Kerala, India 

Role of Adipocytokines and Inflammatory 

Processes in Insulin Resistance 

CORPORATE MEMBERS 

Leaders ($100,000 and over) 


Patrons ($25,000 to $49,999) 

Beckman Coulter 

PerkinElmer 

Olympus America Inc. 

Contributors ($10,000 to $24,999) 

BD Diagnostics 

AutoGenomics, Inc. 

Genzyme 

Donors ($100 to $4,999) 

Bio-Research Products, Inc. 

AACC LOCAL SECTIONS & DIVISIONS 

Sponsors ($10,000 to $49,999) 

Midwest Local Section 

TDM & Clinical Toxicology 

Division 

Sustainers ($5,000 to $9,999) 

Chicago Local Section 

Clinical & Diagnostic Immunology 

Division 

Critical and POCT Division 

Management Sciences Division 

Rocky Mountain Local Section 

Southern California Local Section 

Patrons ($1,000 to $4,999) 

Capital Section of the AACC 

Southeast Local Section 

Connecticut Valley Local Section 


history Division 

Carraway-Meites Award for 

Enhancing our Knowledge of 

the History of Clinical Chemistry 

Nathan Radin, PhD, Stone Mountain, Ga. 

inDustry Division 

Louis J. Dunka Jr. Memorial 

Service Award 


Best Abstract of Interest 

to the Industry Division 


lAborAtory informAtion systems 

AnD meDiCAl informAtiCs Division 

Award for Outstanding Research 

in Medical Informatics 

Ken Blick, PhD, University of Oklahoma 

Health Science Center, 

Oklahoma City, Okla. 

Real-Time quality control based on patient 

running means (PRM) for total laboratory 

automation (TLA) using Beckman Coulter 

(BCI) DL2000 middleware. 

liPoProteins AnD vAsCulAr DiseAses Division 

Cooper Award for Outstanding Contributions 

to Service in the Area of 

Lipoproteins and Vascular Diseases 

Ishwarlal Jialal, MD, PhD, UC Davis 

Medical Center, Sacramento, Calif. 

Pacific Biometrics Research Foundation 

Award for Contributions to the 

Technology of Clinical Chemistry 

Takashi Miida, MD, PhD, Juntendo University 

School of medicine, Tokyo, Japan 

International Travel Grant 

Lorena Ivona Stefan, MSc, 

Clinical Emergency Hospital, Romania 

Outstanding Article in 

Fats of Life Newsletter 


Poster Award Winners 

Three awards are given for outstanding 

abstracts accepted in the area of lipopro- 

teins and vascular diseases. Recipients are 

announced in Fats of Life. 

mAnAgement sCienCes Division 

Award for Outstanding Research in 

Management Sciences 

Ping Li, West China Hospital, 

Chengdu, China 

Application of six sigma metric to assess total 

quality performance of clinical laboratory. 

moleCulAr PAthology Division 

Outstanding Research in the 

Area of Molecular Pathology 

or Pharmacogenomics 

Alicia Algeciras-Schimnich, PhD, 

Mayo Clinic, Rochester, Minn. 

Clinical assay for the detection of the 

PAX8-PPARγ granslocation in follicular 

thyroid cancer 

Young Investigator Award for 

Outstanding Research in Molecular 


Grigory Tsaur, MD, PhD, 

Regional Children’s Hospital, 

Yekaterinburg, Russian Federation 

Minimal residual disease monitoring of 

MLL-EPS15 fusion gene in infants’ acute 

leukemia using quantitative real-time PCR 

assay. 

Student/Medical Technologist Award 

for Outstanding Research in Molecular 


Zhen Yang, MS, University of Texas 

Medical Branch, Galveston, Texas 

HIV-1 genotypic resistance test in specimens 

with a low viral load 

nutrition Division 

Gary Labbe Award for Contributions 

to Laboratory Assessment of 

Nutritional Status 

Jose M. Ordovas, PhD, Tufts University, 

Boston, Mass. 


Nutrition. 1st Place. 

Yanping Gong, PhD, University of 

Toronto, Toronto, Ontario, Canada 

Chronic pain as a sign of a higher vitamin D 

requirement 


Nutrition. 2nd Place. 

Nadheige Lochard, PhD, CHU Ste- 

Justine, University of Montreal, Montreal, 

QC, Canada 

Effect of paraoxonase 1 gene polymorphism 

on lipid profile in children and adolescents 

PeDiAtriC & mAternAl-fetAl Division 

Award for Outstanding 

Contributions to Pediatric and 

Maternal-Fetal Clinical Chemistry 

John E. Sherwin, PhD, Perkin Elmer, 

Huntington Station, N.Y. 

Best Poster Award 

Oluyemi Akinloye, PhD, 

Ladoke Akintola University of Technology, 

Osogbo, Osun State, Nigeria 

Relationship between maternal and infants’ 

plasma and breast milk levels of some 

selected micronutrients. 

Student and Young 

Faculty Poster Award 

Octavia Peck-Palmer, PhD, 

Washington University School of Medicine, 

St. Louis, Mo. 

Intra-individual variability of basic chemistry 

tests in a pediatric population. 

Alexander Haliassos, MD, PhD, 

Diamedica, Athens, Greece 

Evaluation of pregnancy associated plasma 

protein A (PAPP-A) and free beta human 

chorionic gonadotrophin (free ß-hCG) 

on Siemens Immulite in comparison with 

Brahms Kryptor analyzer. 

therAPeutiC Drug monitoring 

& CliniCAl toxiCology Division 

UTAK Young Investigator Award 

Paul Jannetto, PhD, Medical College of 

Wisconsin, Milwaukee, Wis. 

VAN SLYKE FOUNDATION HONOR ROLL 

The Foundation gratefully recognizes contributors who made donations totaling $100 or more from January 1, 2007, through May 20, 2008. 

On behalf of all the promising science students and laboratorians in the developing world who received VSF grants and awards, 

we extend our sincere thanks. These contributions have helped to advance clinical laboratory medicine worldwide. 

Lipoproteins & Vascular Diseases 

Division 

Pacific Northwest Local Section 

Molecular Pathology Division 

Contributors ($100 to $999) 

North Carolina Local Section 

INDIVIDUAL MEMBERS 

Leaders ($100,000 and over) 

Gopal Savjani 

Gerald and Sandy Gallwas 

Benefactor ($50,000 to $99,000) 

Thomas Adams 

Sponsors ($10,000 to $49,999) 

Jocelyn Hicks 

Richard Nadeau 

Mary Lou Gantzer 

Robert Habig 

Sustainers ($5,000 to $9,999) 

Robert Stout 

Laurence Demers 

D. Robert Dufour 

Jan Krouwer 

Marilyn A. Huestis 

Patrons ($1,000 to $4,999) 

Nathan Gochman 

Helen Free 

Susan Evans 

Basil Doumas 

Geoffrey Moyer 

Masashi Itano 

Alan Runck 

Charles Galanaugh 

Robert Murray 

Mathias Muller 

John Sherwin 

Mary Burritt 

Fred Apple 

Gerald Cooper 

Darrin Scherago 

William Luft 

Frederick Brazda 

Julius Kerkay 

Ann Gronowski 

Roger Calam 

Carl Garber 

Don Miyada 

James Faix 

Imre Fischer 

Tsan Liu 

Michael Kleerekoper 

Susan Gross 

Donald Powers 

Marion Mixson 

Kathleen Quill 

Morton Schwartz 

Ruth McNair 

Jacob Levine 

Richard Lent 

Gail Mutnik 

Contributors ($100 to 

$999) 

Larry Broussard 

Thomas Williams 

John O'Malley 

Sally Hojvat 

Earl Soules 

Deji Deji 

Daniel Farkas 

Christine Papadea 

Enno Logemann 

Douglas Stickle 

James Ritchie 

Isaac Rosenzweig 

Jesse Goodwin 

Stephen Stroupe 

Paula Santrach 

Charles Hawker 

Donald Forman 

Clara Sumeghy 

Ching-Nan Ou 

Harold Choitz 

Samuel Mathews 

Esokpan Ebose 

Richard Collins 

Katherine Chen 

Robert Johnson 

Carlotta Eisen 

Edward Ashwood 

Eugene Garcia 

Phyllis Feinblum 

Jean Travers 

William Roberts 

Carolyn Bergkuist 

David Grenache 

Harold Brown 

Gary Myers 

Harold Williams 

Alan Wu 

Akin Williams 

Sarah Mook 

Cheong Ngoi 

Beryl Weinstein 

Dan Chen 

Corinne Fantz 

Kevin Cavanagh 

Steven Lobel 

Masayuki Totani 

Nori Jones 

Sophia Kakari 

David Keren 

Toshifumi Niwa 

John Mason 

Michael Sheff 

Nathan Radin 

Claudio Sampaio 

William Feldman 

James McQuaid 

Daniel Hoefner 

Howard Ludwick 

Stanley Lo 

Michael Bennett 

Harald Drews 

Harvey Kaufman 

Dalamaga Androniki 

Irwin Oreskes 

Luciano Marchetti 

Barbara Cooper 

Adebowale Alabi 

James Smith 

Olusegun Mojiminiyi 

Geza Bodor 

Paula Childs 

Juan Paz-Fernandez 

Harold Baker 

Mary Jackson 

Linda Gorman 

Arturo Vargas 

Bobby Boyanton 

Barbara Zehnbauer 

Philip Boglo 

Barclay Whitaker 

Patricia Jones 

Tina Sky 

John Williams 

Gregory Tsongalis 

Willard Faulkner 

Maggie Bruno 

Penelope Jones 

Patrick St. Louis 

Gyorgy Abel 

James Nichols 

Special Gifts 

The Foundation extends special thanks to Mr. 

Gopal Savjani, whose generous donation created 

the Past Presidents’ Scholarships for Post-doctoral 

Training. To date, four scholarships have been 

awarded in ComACC-approved training programs. 

The VSF also thanks Jerry and Sandy Gallwas 

for their ongoing generosity that funds AACC 

memberships, travel grants, and educational 

opportunities for deserving scientists from the 

developing world. 

Planned Gifts 

The VSF gratefully acknowledges the following 

generous bequests from the following donors: 

Earl Scherago 

Elizabeth K. Smith 

Contributions to the VSF Memorial Fund were 

made in memory of Joseph Napolitano.


3M Medical Diagnostics . . . . . . . . . . . .3921 

A/C Diagnostics LLC . . . . . . . . . . . . . . . .2148 

A2LA ................................344 

AACC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3629 

AAFP-Laboratory Proficiency Testing .162 

Aalto Scientific, Ltd. . . . . . . . . . . . . . . . .3833 

Abaxis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .366 

Abbott Diagnostics .................1507 

Abbott Diagnostics Labs Are Vital . . .1811 

AbD Serotec . . . . . . . . . . . . . . . . . . . . . . .3733 

Access Bio, Inc. . . . . . . . . . . . . . . . . . . . . .4149 

Access Biological . . . . . . . . . . . . . . . . . . .1965 

AccuTest, Inc. . . . . . . . . . . . . . . . . . . . . . . .3910 

ACON Laboratories, Inc. . . . . . . . . . . . . .1038 

AcroMetrix . . . . . . . . . . . . . . . . . . . . . . . . .4109 

Adaltis US Inc. . . . . . . . . . . . . . . . . . . . . . .3215 

Adaptive MFG. Technologies Inc. . . . .2353 

ADEMTECH . . . . . . . . . . . . . . . . . . . . . . . . . .109 

Adhesives Research, Inc. . . . . . . . . . . . .1847 

Adicon Clinical Laboratories, Inc. . . . .1042 

Advance . . . . . . . . . . . . . . . . . . . . . . . . . . .3049 

Advanced Instruments, Inc. . . . . . . . . . .230 

Advanced Liquid Logic . . . . . . . . . . . . . .164 

Advanced Microdevices Pvt. Ltd. . . . .1769 

Aesku Diagnostics . . . . . . . . . . . . . . . . . .1653 

Affymetrix, Inc. . . . . . . . . . . . . . . . . . . . . . .410 

Agilent Technologies . . . . . . . . . . . . . . .3148 

Ahlstrom . . . . . . . . . . . . . . . . . . . . . . . . . . .4108 

AID GmbH ...........................126 

Alfa Scientific Designs, Inc. . . . . . . . . . . .156 

Alfa Wassermann 

Diagnostic Technologies . . . . . . . . .1031 

ALIFAX SPA . . . . . . . . . . . . . . . . . . . . . . . . .3315 

ALPCO Diagnostics . . . . . . . . . . . . . . . . .1546 

AMA Scientific, LLC . . . . . . . . . . . . . . . . .4104 

Amano Enzyme USA Co., Ltd. . . . . . . . .130 

Amedica Biotech, Inc. . . . . . . . . . . . . . . .1963 

American Bio Medica Corporation . . . .258 

American Diagnostica Inc. . . . . . . . . . .1044 

American Medical Technologists . . . . .118 

American Proficiency Institute . . . . . .3628 

ASCLS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3039 

American Society for 

Clinical Pathology . . . . . . . . . . . . . . . .4125 

Ameritek USA . . . . . . . . . . . . . . . . . . . . . . .113 

Amic AB . . . . . . . . . . . . . . . . . . . . . . . . . . . . .261 

Analis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1129 

Analyticon Biotechnologies AG . . . . .1461 

Anew International . . . . . . . . . . . . . . . . .3703 

Ani Biotech Oy & 

AniLabsystems Ltd ...............1756 

Antek HealthWare . . . . . . . . . . . . . . . . . .2115 

Applied Biosystems ..................903 

APS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2067 

Argene Inc. . . . . . . . . . . . . . . . . . . . . . . . . .2268 

Aries Filterworks, 

Division of ResinTech .............1859 

Arista Biologicals Inc. . . . . . . . . . . . . . . .2152 

Arlington Scientific - ASI . . . . . . . . . . . .1524 

Artel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .757 

ARUP Laboratories . . . . . . . . . . . . . . . . .1039 

ARUP Laboratories . . . . . . . . . . . . . . . . .4032 

Asahi Kasei Pharma Corporation . . . . .120 

ASCO Numatics .....................2253 

ASSEL - AMS ........................1563 

Asuragen, Inc. . . . . . . . . . . . . . . . . . . . . . .3046 

Athera Biotechnologies .............1359 

Atherotech . . . . . . . . . . . . . . . . . . . . . . . . . .133 

Atlas Link, Inc. . . . . . . . . . . . . . . . . . . . . . . .169 

Audit MicroControls, Inc. ............3829 

Autobio Diagnostics Co. Ltd. . . . . . . . . .204 

AutoGenomics Inc. . . . . . . . . . . . . . . . . .1023 

Awareness Technology, Inc. . . . . . . . . .1803 

AWEX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1130 

Axis-Shield . . . . . . . . . . . . . . . . . . . . . . . . . .357 

AZOG, Inc. ...........................142 

Bangs Laboratories, Inc. .............1014 

Baytree Leasing ......................123 

BBInternational . . . . . . . . . . . . . . . . . . . . .3431 

BD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .339 

BD Lee Laboratories . . . . . . . . . . . . . . . .1661 

Beaufort Advisors ....................115 

Beckman Coulter, Inc. . . . . . . . . . . . . . . .2025 

Beijing Kinghawk Pharmaceuticals . .2954 

Beijing Shining Sun 

Technology Co., Ltd. . . . . . . . . . . . . . .3716 

Berthold Detection Systems GmbH . .1863 

BERTHOLD TECHNOLOGIES GmbH ...1355 

Bestgen Biotech Corp. . . . . . . . . . . . . . .3929 

Binding Site Inc., The . . . . . . . . . . . . . . . . .923 

Binding Site Inc., The . . . . . . . . . . . . . . . .2153 

BioAssay Works, LLC .................3923 

Bio-Bottle Ltd . . . . . . . . . . . . . . . . . . . . . .1466 

BioCheck, Inc. . . . . . . . . . . . . . . . . . . . . . .2262 

Bio-Chem Fluidics . . . . . . . . . . . . . . . . . .1960 

BioDot, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .3912 

BIOER TECHNOLOGY Co., LTD ........1553 

BioHelix Corporation . . . . . . . . . . . . . . . .362 

BIOHIT, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .3615 

BioKit SA . . . . . . . . . . . . . . . . . . . . . . . . . . . .543 

Biological Specialty Corporation . . . .2364 

Biologix Research Co. . . . . . . . . . . . . . . .2160 

BIOLYPH, LLC . . . . . . . . . . . . . . . . . . . . . . .1860 

Biomat . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1358 

BioMed Resource Inc. . . . . . . . . . . . . . . .2358 

Biomedix . . . . . . . . . . . . . . . . . . . . . . . . . . . .465 

bioMerieux, Inc. . . . . . . . . . . . . . . . . . . . .1743 

Bioneer Corporation . . . . . . . . . . . . . . . .1662 

BioPorto Diagnostics . . . . . . . . . . . . . . .1259 

BioProcessing, Inc. . . . . . . . . . . . . . . . . . . .208 

Bio-Rad Laboratories . . . . . . . . . . . . . . .1239 

Biosearch Technologies, Inc. . . . . . . . . .101 

Biosigma S.R.L. . . . . . . . . . . . . . . . . . . . . .1554 

Biosino Bio-Technology 

& Science Inc. . . . . . . . . . . . . . . . . . . . .2851 

Biosource . . . . . . . . . . . . . . . . . . . . . . . . . .1127 

BIOSPACIFIC . . . . . . . . . . . . . . . . . . . . . . . .1760 

Bio-Synthesis, Inc. . . . . . . . . . . . . . . . . . . .960 

BioTek Instruments, Inc. . . . . . . . . . . . . . .244 

Biotest Diagnostic Corp . . . . . . . . . . . . .3011 

BioTX Automation, Inc. . . . . . . . . . . . . . .768 

BioVentures, Inc. . . . . . . . . . . . . . . . . . . . .4051 

Biowin . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1125 

BIT Analytical Instruments . . . . . . . . . .2267 

BloodCenter of Wisconsin . . . . . . . . . . .968 

Blue Cross Bio-Medical 

Beijing Co., Ltd. . . . . . . . . . . . . . . . . . .1357 

BODITECH MED Inc. . . . . . . . . . . . . . . . . .161 

BOMI IBERICA, S.A. . . . . . . . . . . . . . . . . . . .349 

Brady Corporation . . . . . . . . . . . . . . . . . .4043 

Burkert Fluid Control Systems . . . . . . . .657 

C & A Scientific Co., Inc. . . . . . . . . . . . . .4145 

CalBioreagents . . . . . . . . . . . . . . . . . . . . .3812 

Calbiotech Inc . . . . . . . . . . . . . . . . . . . . . .2910 

Caldon Bioscience . . . . . . . . . . . . . . . . . .3808 

Calypte Biomedical Corporation . . . .4045 

Calzyme Laboratories, Inc. . . . . . . . . . .2249 

Cambridge Consultants . . . . . . . . . . . . . .311 

CapitalBio Corporation . . . . . . . . . . . . .1667 

Capralogics Inc . . . . . . . . . . . . . . . . . . . . . .112 

Capricorn Products LLC . . . . . . . . . . . . . .214 

Cardinal Health . . . . . . . . . . . . . . . . . . . . . .843 

CARE Diagnostica Int’l . . . . . . . . . . . . . .1046 

CareEvolve . . . . . . . . . . . . . . . . . . . . . . . . . .868 

Carolina Chemistries . . . . . . . . . . . . . . . .1910 

Carville Ltd . . . . . . . . . . . . . . . . . . . . . . . . .1767 

CCS Robotics . . . . . . . . . . . . . . . . . . . . . . . .869 

CellaVision . . . . . . . . . . . . . . . . . . . . . . . . . .959 

Cellestis, Inc. . . . . . . . . . . . . . . . . . . . . . . . .238 

Centerchem Inc. . . . . . . . . . . . . . . . . . . . .1845 

Centers for Disease Control 

& Prevention . . . . . . . . . . . . . . . . . . . . .4018 

Centers for Medicare & 

Medicaid Svcs . . . . . . . . . . . . . . . . . . . .9006 

Cepheid . . . . . . . . . . . . . . . . . . . . . . . . . . . .2715 

CERTEST BIOTEC s.l. . . . . . . . . . . . . . . . . .448 

Chembio Diagnostic Systems, Inc. . . . .160 

Chempaq Inc. .......................163 

Chemtron Biotech Inc. . . . . . . . . . . . . . .1867 

ChildLab . . . . . . . . . . . . . . . . . . . . . . . . . . .3713 

China Diagnostics Medical 

Corporation . . . . . . . . . . . . . . . . . . . . . .1265 

Chongqing Tianhai Medical 

Equipment Co. . . . . . . . . . . . . . . . . . . .3146 

CHROMSYSTEMS GmbH . . . . . . . . . . . .2442 

Chungdo Pharm. Co. Ltd. . . . . . . . . . . .1467 

CIS Biotech, Inc & Grace Laboratories 1864 

Cleveland Clinic Reference 

Laboratory . . . . . . . . . . . . . . . . . . . . . . . .564 

Clinical & Laboratory Standards Inst 9008 

Clinical Diagnostic Solutions, Inc. . . . .308 

Clinical Lab Products . . . . . . . . . . . . . . .3824 

CLINIQA Corporation . . . . . . . . . . . . . . . .312 

CMEF/IVD - China Int’l 

Med. Equip. Fair . . . . . . . . . . . . . . . . . .1354 

COLA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3714 

College of American Pathologists . . .2215 

CompHealth . . . . . . . . . . . . . . . . . . . . . . .4012 

Comtron Corp. . . . . . . . . . . . . . . . . . . . . . .769 

Conductive Technologies Inc. . . . . . . .2157 

Cooper - Atkins Corporation . . . . . . . . .132 

Copan Diagnostics, Inc. . . . . . . . . . . . . . .220 

Corgenix . . . . . . . . . . . . . . . . . . . . . . . . . . .3529 

Coris Bioconcept . . . . . . . . . . . . . . . . . . .1224 

CORMAY S.A. . . . . . . . . . . . . . . . . . . . . . . .1267 

Creative Laboratory Products Inc. . . .4009 

Creatv Microtech . . . . . . . . . . . . . . . . . . .4016 

Critical Diagnostic . . . . . . . . . . . . . . . . . .3931 

Crony Instruments S.r.l. . . . . . . . . . . . . .1064 

Cryo Bio Systems . . . . . . . . . . . . . . . . . . . .669 

CSP Technologies, Inc. . . . . . . . . . . . . . .4047 

CTD Inc. & Beijing Bio Dev. Ltd. . . . . . .2368 

CTK Biotech, Inc. . . . . . . . . . . . . . . . . . . . .1263 

DA’AN GENE CO., LTD. . . . . . . . . . . . . . .1465 

Dartmouth Hitchcock 

Medical Center . . . . . . . . . . . . . . . . . . .3811 

DAS Srl . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1453 

Data Innovations, Inc. . . . . . . . . . . . . . . .2009 

David G. Rhoads Associates, Inc. . . . . .1030 

Dawning Technologies, Inc. . . . . . . . . .3830 

DENKA SEIKEN CO., LTD. . . . . . . . . . . . .3207 

DenLine Uniforms, Inc. . . . . . . . . . . . . .3045 

Desert Biologicals/Omega Biologicals 202 

Dexter Magnetic Technologies, Inc. . .964 

DGP Group Ltd. . . . . . . . . . . . . . . . . . . . .2850 

diaDexus, Inc. . . . . . . . . . . . . . . . . . . . . . .4239 

Diagam . . . . . . . . . . . . . . . . . . . . . . . . . . . .1226 

Diagnostic Automation / 

Cortez Diagnostic ................3531 

Diagnostic Consulting Network . . . . .2252 

Diagnostic Laminations Engineering 209 

Diagnostica Stago, Inc. . . . . . . . . . . . . .3027 

DIALAB G.m.b.H. . . . . . . . . . . . . . . . . . . .1356 

Diamedix Corporation ..............2521 

Diametra SRL . . . . . . . . . . . . . . . . . . . . . .1668 

DiaMond Jordan . . . . . . . . . . . . . . . . . . .4148 

DiaSorin . . . . . . . . . . . . . . . . . . . . . . . . . . .2139 

DiaSys Diagnostic Systems GmbH . . .3417 

Diatron Messtechnik AMBH . . . . . . . . .1362 

Diazyme Laboratories . . . . . . . . . . . . . .2421 

DIBA Industries, Inc. . . . . . . . . . . . . . . . .1957 

DIESSE Diagnostica Senese S.p.A . . .3321 

Dirui Industrial Co., Ltd. .............1468 

DLD Diagnostika GmbH . . . . . . . . . . . .1861 

DNA Genotek Inc. . . . . . . . . . . . . . . . . . .4049 

DNA Vision . . . . . . . . . . . . . . . . . . . . . . . . .1228 

DOCRO, Inc. . . . . . . . . . . . . . . . . . . . . . . . .1753 

Double Q Lab . . . . . . . . . . . . . . . . . . . . . . .111 

Double-Dove Group Co., Ltd. . . . . . . .4142 

Dragon Medical (Shanghai) Ltd. . . . .3915 

Drew Scientific, Inc. . . . . . . . . . . . . . . . . .1930 

DRG International, Inc. ...............945 

Drucker Company, The . . . . . . . . . . . . . . .200 

Drummond Scientific . . . . . . . . . . . . . . .2625 

D-Tek . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1230 

DXS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2414 

DYNEX Technologies Inc. . . . . . . . . . . .3111 

E2V Biosensors Ltd . . . . . . . . . . . . . . . . .2956 

EastCoast Bio, Inc. . . . . . . . . . . . . . . . . . .2063 

Egemin Automation Inc. . . . . . . . . . . . . .861 

EMD Chemicals, Inc. . . . . . . . . . . . . . . . .1953 

ENV Services Inc. . . . . . . . . . . . . . . . . . . .2846 

Epocal Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .264 

Eppendorf North America . . . . . . . . . .1431 

EQUITECH-BIO, Inc. . . . . . . . . . . . . . . . . .4143 

Erba Diagnostics Mannheim GmbH 2515 

Ercon Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .2949 

ESA Biosciences, Inc. . . . . . . . . . . . . . . . .3210 

Estapor/EMD Chemical . . . . . . . . . . . . .4243 

Eurogentec NA Inc. . . . . . . . . . . . . . . . . .4106 

Euroimmun AG . . . . . . . . . . . . . . . . . . . . .1061 

Eurotrol . . . . . . . . . . . . . . . . . . . . . . . . . . . .1902 

EVERGREEN SCIENTIFIC . . . . . . . . . . . . .4005 

Excel Scientific, Inc. . . . . . . . . . . . . . . . . .1866 

Express Diagnostics Inc. Int’l . . . . . . . . .110 

Fapon Biotech Inc. .................3717 

Ferrotec (USA) Corporation . . . . . . . . .1868 

Fertility Technology Resources, Inc. .3715 

Filtrona Fibertec . . . . . . . . . . . . . . . . . . . .1853 

Fine Care Biosystems . . . . . . . . . . . . . . .2946 

Fisher Healthcare . . . . . . . . . . . . . . . . . . .1911 

Fluid Metering, Inc. . . . . . . . . . . . . . . . . .2049 

Fluidigm Corporation . . . . . . . . . . . . . . .2052 

Focus Diagnostics . . . . . . . . . . . . . . . . . .2015 

Foliage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .565 

Fujirebio Diagnostics, Inc. . . . . . . . . . . .2727 

Furuno Electric Co., Ltd. . . . . . . . . . . . . .2943 

G&L Precision Die Cutting, Inc. . . . . . .2315 

Gale Force Software Corporation . . . .1958 

GE Healthcare . . . . . . . . . . . . . . . . . . . . . .2406 

Gema Medical, S.L. . . . . . . . . . . . . . . . . . .451 

Gems Sensors & Controls . . . . . . . . . . .2347 

GeneFluidics . . . . . . . . . . . . . . . . . . . . . . . .265 

Genisphere, Inc. . . . . . . . . . . . . . . . . . . . .1765 

Genius . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1464 

Gen-Probe . . . . . . . . . . . . . . . . . . . . . . . . .3019 

GenVault Corporation . . . . . . . . . . . . . .1663 

GenWay Biotech, Inc. . . . . . . . . . . . . . . .2256 

Genzyme Diagnostics . . . . . . . . . . . . . .1231 

Gerresheimer Wilden GmbH . . . . . . . .3411 

Globe Scientific Inc. . . . . . . . . . . . . . . . . .100 

GMI, INC. . . . . . . . . . . . . . . . . . . . . . . . . . . .2948 

GML . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2356 

Gold Standard Diagnostics Corp . . . .4129 

Golden West Biologicals, Inc. . . . . . . . . .145 

Greiner Bio-One, Inc. . . . . . . . . . . . . . . .3327 

Grifols Diagnostics- 

Diagnostic Division . . . . . . . . . . . . . .4025 

Haemoscope Corporation . . . . . . . . . .4022 

Hamilton Company . . . . . . . . . . . . . . . . .2043 

HandyLab, Inc. . . . . . . . . . . . . . . . . . . . . .1143 

Hanlab Corporation . . . . . . . . . . . . . . . .3906 

Hardy Diagnostics . . . . . . . . . . . . . . . . . . .128 

Harlan Bioproducts for Science . . . . .1659 

Haydon Switch & Instrument, Inc. . . .2053 

Health Care Logisitics . . . . . . . . . . . . . . .1167 

Helena Laboratories . . . . . . . . . . . . . . . . .556 

Helena Laboratories - POC . . . . . . . . . . .457 

HELMER . . . . . . . . . . . . . . . . . . . . . . . . . . . . .915 

Hemagen Diagnostics, Inc. . . . . . . . . .3310 

HemoCue Inc. . . . . . . . . . . . . . . . . . . . . . . .360 

Hemosure, Inc./WHPM, Inc. . . . . . . . . .4031 

Himedia Laboratories Pvt. Limited . . .2319 

HistoRx, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .969 

Hoover Precision Products, LLC . . . . .2154 

HORIBA ABX Diagnostics ...........1053 

HRA Research . . . . . . . . . . . . . . . . . . . . . . .309 

HTL - Strefa Inc. . . . . . . . . . . . . . . . . . . . .4147 

Hubit Co., Ltd. . . . . . . . . . . . . . . . . . . . . . .1469 

Human GmbH . . . . . . . . . . . . . . . . . . . . . .1656 

HyTest Ltd. . . . . . . . . . . . . . . . . . . . . . . . . .3802 

I.C.A. Corporation . . . . . . . . . . . . . . . . . . . .867 

IBL - America . . . . . . . . . . . . . . . . . . . . . . . .243 

IBL - Transatlantic Corp. . . . . . . . . . . . . . .106 

Idex Health & Science . . . . . . . . . . . . . . .1903 

IFCC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9001 

Illumina . . . . . . . . . . . . . . . . . . . . . . . . . . . .2711 

ILS Innovative Labor Systeme GmbH 864 

Imageinterpret GmbH . . . . . . . . . . . . . . .865 

IMMCO Diagnostics . . . . . . . . . . . . . . . .3905 

Immucor, Inc. . . . . . . . . . . . . . . . . . . . . . .2926 

Immunicon Corporation . . . . . . . . . . . .3807 

Immuno Concepts . . . . . . . . . . . . . . . . . .3705 

Immunodiagnostic Systems, Inc. . . . .2449 

IMPAC Medical Systems, Inc. . . . . . . . . .138 

InBios International, Inc. . . . . . . . . . . . . .114 

IND Diagnostic Inc. . . . . . . . . . . . . . . . . .1669 

Indiana Pathology Images . . . . . . . . . . .218 

Indicia Biotechnology . . . . . . . . . . . . . .2261 

2008 ANNUAL MEETING 

List of exhibitors

CliniCal laboratory news Special edition 19 

Infolab International Corporation . . .4041 

Innovacon Inc. . . . . . . . . . . . . . . . . . . . . .4013 

INOVA Diagnostics, Inc. . . . . . . . . . . . . . .551 

INSTRU-MED INC . . . . . . . . . . . . . . . . . . .3928 

Instrumentation Laboratory ........2703 

InTec Products, Inc. . . . . . . . . . . . . . . . . .2856 

Integrated DNA Technologies, Inc. . .1857 

Integrated Lab Automation 

Solution, Inc. . . . . . . . . . . . . . . . . . . . . .1647 

INTERBIOLAB, Inc. . . . . . . . . . . . . . . . . . .4004 

International Immuno-Diagnostics . .364 

International Immunology 

Corporation . . . . . . . . . . . . . . . . . . . . . .1526 

Inverness Medical Professional . . . . . .2439 

Invetech . . . . . . . . . . . . . . . . . . . . . . . . . . .1825 

Invitrogen . . . . . . . . . . . . . . . . . . . . . . . . . .965 

IQuum, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .1047 

IRIS Diagnostics . . . . . . . . . . . . . . . . . . . .2427 

i-SENS, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .1363 

Isensix, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .4226 

ITC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .531 

IVD Research, Inc. . . . . . . . . . . . . . . . . . . .104 

IVD Technologies . . . . . . . . . . . . . . . . . . .2264 

IVD Technology Magazine . . . . . . . . . .1665 

IVEK Corporation . . . . . . . . . . . . . . . . . . .2416 

Iwaki America Inc. . . . . . . . . . . . . . . . . . .1964 

Jackson ImmunoResearch 

Laboratories, Inc . . . . . . . . . . . . . . . . .2061 

JAJ International . . . . . . . . . . . . . . . . . . .4039 

Japan Association . . . . . . . . . . . . . . . . . .9005 

JAS Diagnostics, Inc. . . . . . . . . . . . . . . . .226 

JCAHO . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1944 

Jiangsu Kangjian Medical 

Apparatus Co. . . . . . . . . . . . . . . . . . . .2955 

JSR Corporation . . . . . . . . . . . . . . . . . . . .2854 

Kaiser Permanente . . . . . . . . . . . . . . . . .2751 

Kalorama Information . . . . . . . . . . . . . .3816 

Kamiya Biomedical Company . . . . . . .1839 

Kem-En-Tec Diagnostics . . . . . . . . . . . . .346 

KIKKOMAN CORPORATION . . . . . . . . . . .212 

Kinematic Automation Inc. . . . . . . . . . .851 

KMC Systems, Inc. . . . . . . . . . . . . . . . . . . .909 

KNF Neuberger Inc. ................3828 

KPL, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . .2266 

KRONUS, Inc. . . . . . . . . . . . . . . . . . . . . . . .3231 

Lab Medica . . . . . . . . . . . . . . . . . . . . . . . .9004 

Labconco Corporation . . . . . . . . . . . . . .4117 

LabCorp-Esoterix . . . . . . . . . . . . . . . . . . .1153 

LabiTec GmbH, Germany . . . . . . . . . . . .1458 

Labnovation Technologies, Inc . . . . . . .121 

Labtest . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1352 

Lampire Biological Laboratories . . . . .3211 

LasX-Precision Medical 

Converting Group . . . . . . . . . . . . . . . .147 

Lathrop Engineering . . . . . . . . . . . . . . .1010 

Lattice Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .143 

Lee Company, The . . . . . . . . . . . . . . . . . .2747 

Lendell Manufacturing Inc. . . . . . . . . . .141 

Lifepoint Informatics . . . . . . . . . . . . . . .3806 

LifeScan Inc. . . . . . . . . . . . . . . . . . . . . . . .1539 

LifeSign LLC . . . . . . . . . . . . . . . . . . . . . . . . .266 

Lighthouse Recruiting . . . . . . . . . . . . . . .153 

Liofilchem S.R.L. . . . . . . . . . . . . . . . . . . .1561 

LipoScience, Inc. . . . . . . . . . . . . . . . . . . .1947 

LRE Medical, an Esterline Company 2909 

Lucigen Corporation . . . . . . . . . . . . . . .2066 

Luminex Corporation . . . . . . . . . . . . . . . .525 

LW Scientific . . . . . . . . . . . . . . . . . . . . . . .4245 

Lydall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3810 

m.u.t GmbH ........................3303 

Mack Information Systems . . . . . . . . . . .866 

Magellan Biosciences, Inc./ 

Dynex Tech. . . . . . . . . . . . . . . . . . . . . .3115 

Magna Bio Sciences . . . . . . . . . . . . . . . . .305 

Magnasense Ltd. . . . . . . . . . . . . . . . . . . . .167 

Magnisense . . . . . . . . . . . . . . . . . . . . . . . .1353 

MagQu Co. . . . . . . . . . . . . . . . . . . . . . . . . .2855 

MagSense Life Sciences, Inc. . . . . . . . .3044 

Magsphere Inc. . . . . . . . . . . . . . . . . . . . . .1763 

Maine Biotechnology Services, Inc. . .1429 

Maine Standards Company . . . . . . . . .4242 

Man & Machine, Inc. . . . . . . . . . . . . . . . . .125 

Mayo Medical Laboratories . . . . . . . . .2627 

McKesson ..........................2343 

Mechatronics . . . . . . . . . . . . . . . . . . . . . .1443 

Med Travelers . . . . . . . . . . . . . . . . . . . . . .3814 

Medcompare . . . . . . . . . . . . . . . . . . . . . .3933 

Medica 2007/ Messe Duesseldorf . . .2060 

Medica Corporation . . . . . . . . . . . . . . . .2307 

Medical Automation Systems . . . . . . . .467 

Medical Courier Elite . . . . . . . . . . . . . . .2069 

Medical Device Consultants, Inc. . . . . .342 

Medical Device Safety Service GmbH 3932 

Medical Electronic Systems, LLC . . . .4113 

Medical Laboratory Evaluation(MLE) .2810 

Medical Staffing Network Inc. . . . . . .4119 

Medicon Hellas S A . . . . . . . . . . . . . . . . .1654 

MediFleet . . . . . . . . . . . . . . . . . . . . . . . . . .4246 

Medivative . . . . . . . . . . . . . . . . . . . . . . . . .4024 

Medix Biochemica . . . . . . . . . . . . . . . . . .3817 

MEDTOX Laboratories, Inc. . . . . . . . . . . .316 

Medtronic, Inc. . . . . . . . . . . . . . . . . . . . . . .461 

Melet Schloesing Laboratories . . . . . . .122 

Mercodia Inc. . . . . . . . . . . . . . . . . . . . . . .2950 

Meridian Life Science, Inc. . . . . . . . . . . .146 

Merlin Labs, Inc. ....................3818 

Metro Mold & Design, Inc. . . . . . . . . . .1764 

MGM Instruments, Inc. . . . . . . . . . . . . . .3229 

Michigan Diagnostics, LLC . . . . . . . . . . .108 

MICROLIT . . . . . . . . . . . . . . . . . . . . . . . . . .1366 

Microscan Systems, Inc. . . . . . . . . . . . . . .562 

Microsens Iseao . . . . . . . . . . . . . . . . . . . .3042 

Midland BioProducts Corp . . . . . . . . . .2718 

Millenia Diagnostics, Inc. . . . . . . . . . . . . .144 

Millipore Corporation . . . . . . . . . . . . . . . .415 

MiniFAB . . . . . . . . . . . . . . . . . . . . . . . . . . . .4144 

MiniGrip . . . . . . . . . . . . . . . . . . . . . . . . . . .4230 

Minitubes . . . . . . . . . . . . . . . . . . . . . . . . . .1652 

MiraVista Diagnostics/SSI Products . .2848 

Mitsubishi Chemical Medience 

Corporation . . . . . . . . . . . . . . . . . . . . . .2446 

MLO-Medical Laboratory Observer 3913 

MNX - Midnite Express 

Global Logistics . . . . . . . . . . . . . . . . . .4014 

Monobind Inc. . . . . . . . . . . . . . . . . . . . . .4216 

Moss, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .2724 

Motoman Inc. . . . . . . . . . . . . . . . . . . . . . .1161 

MP Biomedicals . . . . . . . . . . . . . . . . . . . .4208 

MT Promedt Consulting GmbH .....1369 

Multisorb Technologies, Inc. . . . . . . . .3611 

Nano-Ditech Corporation . . . . . . . . . . .2167 

NanoEntek . . . . . . . . . . . . . . . . . . . . . . . . .1067 

Nanogen, Inc. . . . . . . . . . . . . . . . . . . . . . .1547 

Nanosphere, Inc. . . . . . . . . . . . . . . . . . . .3324 

National Jewish Medical & 

Research Ctr. . . . . . . . . . . . . . . . . . . . . .216 

National Registry of 

Certified Chemists . . . . . . . . . . . . . . .3629 

Neogen Corporation . . . . . . . . . . . . . . . .1261 

New England Small Tube . . . . . . . . . . .2258 

NICHIREI BIOSCIENCES, INC. . . . . . . . .1360 

Nikon Instruments Inc. . . . . . . . . . . . . .3825 

NIST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4028 

NOF CORPORATION ................4146 

Norgren Inc. . . . . . . . . . . . . . . . . . . . . . . . .931 

Nor-Lake Scientific . . . . . . . . . . . . . . . . .2348 

Nova Biomedical . . . . . . . . . . . . . . . . . . .1927 

NOVO 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . .1809 

Novx Systems Inc. ..................3924 

NTE, S.A. . . . . . . . . . . . . . . . . . . . . . . . . . . . .553 

NuAire Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .939 

Olympus America, Inc. . . . . . . . . . . . . . . .225 

Omega Diagnostics Group PLC . . . . .1462 

OPERON S.A. . . . . . . . . . . . . . . . . . . . . . . . .460 

OPTI Medical System 

(Formely Osmetech) . . . . . . . . . . . . . . .363 

Opus Healthcare Solutions . . . . . . . . . . .566 

OraSure Technologies, Inc. . . . . . . . . . . .269 

Orchard Software Corp . . . . . . . . . . . . .3513 

Orphee S.A. . . . . . . . . . . . . . . . . . . . . . . . .1255 

Ortho-Clinical Diagnostics . . . . . . . . . .1525 

OSI Optoelectronics . . . . . . . . . . . . . . . .1766 

Osmetech Molecular Diagnostics . . .1002 

Owen Mumford Inc. . . . . . . . . . . . . . . . . .165 

Oxonica Inc. . . . . . . . . . . . . . . . . . . . . . . . .3909 

Oyster Bay Pump Works, Inc. . . . . . . . . .250 

Pall Life Sciences . . . . . . . . . . . . . . . . . . .1752 

Panacea Pharmaceuticals, Inc. . . . . . . .127 

ParagonDx . . . . . . . . . . . . . . . . . . . . . . . . .3729 

Parker Hannifin/Pneutronics . . . . . . . .1968 

Parter Medical Products, Inc. . . . . . . . . .124 

Pathology Outlines.com, Inc. . . . . . . . . .767 

PBM-Princeton BioMeditech 

Corporation . . . . . . . . . . . . . . . . . . . . . .222 

PEAK-Service USA . . . . . . . . . . . . . . . . . . .913 

Peripheral Resources Inc. . . . . . . . . . . . .116 

PerkinElmer Life & Analytical 

Sciences . . . . . . . . . . . . . . . . . . . . . . . . . .953 

Perlong Medical Equipment 

Co., Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . .3054 

Phadia (Pharmacia Diagnostics) . . . . .1331 

Pharmigene, Inc. . . . . . . . . . . . . . . . . . . .4150 

Philosys ............................1367 

Phoenix Diagnostics Inc. . . . . . . . . . . . .4224 

Pointe Scientific, Inc. . . . . . . . . . . . . . . . .2726 

Polymedco, Inc. . . . . . . . . . . . . . . . . . . . .3314 

POLYMICROSPHERES . . . . . . . . . . . . . . .1761 

Precision Systems Inc. . . . . . . . . . . . . . .1542 

Prodesse, Inc. . . . . . . . . . . . . . . . . . . . . . . .131 

Proliant Health and Biologicals . . . . . . .151 

Promega Corporation . . . . . . . . . . . . . . . .663 

Propper MFG. Co., Inc. . . . . . . . . . . . . . .3711 

Psyche Systems Corporation . . . . . . . . .561 

Puritan Medical Products Company . .129 

PVT LabSystems . . . . . . . . . . . . . . . . . . . .3423 

Qarad . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1666 

Qosina/Qosmedix . . . . . . . . . . . . . . . . . .2064 

Quad Five . . . . . . . . . . . . . . . . . . . . . . . . . . .105 

Quality Assured Services, Inc. . . . . . . .4127 

Quantimetrix Corporation . . . . . . . . . .2631 

Quantum Analytics . . . . . . . . . . . . . . . . . .862 

Quest Diagnostics . . . . . . . . . . . . . . . . . .1917 

Quidel Corporation . . . . . . . . . . . . . . . . .3105 

Quimica Clinica Aplicada, S.A. . . . . . . .449 

R&D Systems, Inc. ..................1016 

R2 Diagnostics . . . . . . . . . . . . . . . . . . . . .1906 

Radim SpA . . . . . . . . . . . . . . . . . . . . . . . . .1560 

Radiometer America Inc. . . . . . . . . . . .1939 

RAL, S.A. ............................352 

Randox Laboratories LTD . . . . . . . . . . .1407 

Rayto Life & Analytical 

Sciences Co, Ltd . . . . . . . . . . . . . . . . . . .242 

R-Biopharm AG . . . . . . . . . . . . . . . . . . . . .3510 

RD Plastics Company . . . . . . . . . . . . . . .2065 

Rees Scientific Corporation . . . . . . . . .3925 

Research Organics, Inc. . . . . . . . . . . . . .1961 

Response Biomedical Corp . . . . . . . . . . .369 

RNA Medical . . . . . . . . . . . . . . . . . . . . . . . .468 

RND Group, Inc., The . . . . . . . . . . . . . . . . .139 

Roche . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1007 

Roche Diagnostics - Point of Care . . .1223 

Rocky Mountain Diagnostics . . . . . . . .2847 

Rotek Industries . . . . . . . . . . . . . . . . . . . .3709 

RTEmd-Real Time Enterprises . . . . . . .2257 

SA Scientific LTD . . . . . . . . . . . . . . . . . . . .2360 

Safe-Tec Clinical Products, Inc. . . . . . .2068 

SAF-T-PAK . . . . . . . . . . . . . . . . . . . . . . . . .4248 

Sajar Plastics Inc. . . . . . . . . . . . . . . . . . . .1657 

Saladax Biomedical, Inc. . . . . . . . . . . . .4232 

Salimetrics, LLC . . . . . . . . . . . . . . . . . . . . .117 

Sarstedt, Inc. . . . . . . . . . . . . . . . . . . . . . . .2606 

Sartorius Stedim Biotech . . . . . . . . . . .2352 

Scantibodies Laboratory Inc. . . . . . . .1831 

SCC Soft Computer . . . . . . . . . . . . . . . . .2915 

SCETI K.K. . . . . . . . . . . . . . . . . . . . . . . . . .1566 

SciGene . . . . . . . . . . . . . . . . . . . . . . . . . . . . .766 

SCIMEDX Corporation . . . . . . . . . . . . . .2410 

SCIPAC Ltd. . . . . . . . . . . . . . . . . . . . . . . . .1425 

Scripps Laboratories . . . . . . . . . . . . . . .2149 

SDI Biomed, Inc. . . . . . . . . . . . . . . . . . . . .1066 

Sebia Electrophoresis . . . . . . . . . . . . . . .3309 

Seegene, Inc. . . . . . . . . . . . . . . . . . . . . . . . .213 

Sekisui Medical Co., Ltd . . . . . . . . . . . . .3055 

Select Science . . . . . . . . . . . . . . . . . . . . .3144 

Sensor Electronic Technology, Inc. .2260 

SENTINEL CH SpA . . . . . . . . . . . . . . . . . .3722 

Sepmag Tecnologies . . . . . . . . . . . . . . . .452 

SeraCare Life Sciences . . . . . . . . . . . . . .2714 

Serion Immundiagnostica GmbH . . .3617 

Shanghai Kehua 

Bioengineering Co., Ltd. . . . . . . . . . .1762 

Shanghai Fosun Med-Tech 

Development .....................103 

Shanghai ZJ Bio-Tech Co., Ltd. . . . . . .1660 

Shenzhen Mindray . . . . . . . . . . . . . . . . . .825 

Sias AG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .667 

Siemens Healthcare Diagnostics . . . . .507 

Siemens Water Technologies . . . . . . . .1447 

Sifin GmbH . . . . . . . . . . . . . . . . . . . . . . . . .1552 

SimPort Plastics Ltd . . . . . . . . . . . . . . . . .3723 

Sinnowa Medical Science 

& Technology Co. . . . . . . . . . . . . . . . .1568 

SKC Co., Ltd.(Brand: INCYTO) . . . . . . . .4019 

SLR Research . . . . . . . . . . . . . . . . . . . . . . .2056 

SMC Corporation . . . . . . . . . . . . . . . . . . .2413 

SNIBE - Shenzhen New Industries . . .1559 

Softtech Health . . . . . . . . . . . . . . . . . . . .3917 

Source Scientific, LLC . . . . . . . . . . . . . . .2265 

Southern Biotech . . . . . . . . . . . . . . . . . . .1758 

Span Diagnostics Limited . . . . . . . . . . . .157 

Spherotech Inc. . . . . . . . . . . . . . . . . . . . .2169 

Spinreact, S.A. . . . . . . . . . . . . . . . . . . . . . . .450 

Stanbio Laboratory . . . . . . . . . . . . . . . . .2615 

Standard Diagnostics, Inc. . . . . . . . . . .3328 

STRATEC Biomedical Systems AG . . . . .660 

Strategic Diagnostics Inc. . . . . . . . . . . .2163 

Streck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1938 

Sud-Chemie Performance Packaging 1253 

Super Brush LLC . . . . . . . . . . . . . . . . . . . .2362 

SurModics, Inc. . . . . . . . . . . . . . . . . . . . . . .246 

Swisslog . . . . . . . . . . . . . . . . . . . . . . . . . . .3930 

Synermed Select Partners, Inc. . . . . . .3827 

Syntron Bioresearch, Inc. . . . . . . . . . . . .1967 

Sysmex . . . . . . . . . . . . . . . . . . . . . . . . . . . . .639 

Taidoc Technology Corporation . . . . .3507 

Taigen Bioscience Corporation . . . . . . .567 

Tecan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .405 

Technidata /MediSolution . . . . . . . . . .3306 

Techno Medica Co. Ltd. . . . . . . . . . . . . . .763 

Teco Diagnostics . . . . . . . . . . . . . . . . . . .3624 

Tekra Corporation . . . . . . . . . . . . . . . . . . .256 

TELCOR, Inc. . . . . . . . . . . . . . . . . . . . . . . . . .166 

Tetracore, Inc. . . . . . . . . . . . . . . . . . . . . . . .262 

Therapak Corporation . . . . . . . . . . . . . .3719 

Thermo Scientific . . . . . . . . . . . . . . . . . .2739 

Thin XXS Microtechnology AG . . . . . .2165 

Third Wave Technologies . . . . . . . . . . . .404 

TOKYO BOEKI MACHINERY LTD. . . . .1006 

Tosoh Bioscience, Inc. . . . . . . . . . . . . . .2403 

Toyobo Co., Ltd. 

c/o Shinko American Inc. . . . . . . . . .3813 

Trek Diagnostics Systems, Inc. . . . . . .3214 

TRINA BIOREACTIVES AG . . . . . . . . . . .3525 

Trinity Biotech . . . . . . . . . . . . . . . . . . . . .2105 

TTP Labtech . . . . . . . . . . . . . . . . . . . . . . . .1946 

Tyson Bioresearch, Inc. . . . . . . . . . . . . .1567 

UC San Francisco Medical Center . . . .966 

UNICO . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2166 

United Biotech, Inc. . . . . . . . . . . . . . . . .2269 

University of Virginia Health Systems 2450 

Urit Medical Electronic Co., Ltd . . . . . .3710 

UTAK Laboratories, Inc. . . . . . . . . . . . . .1544 

ValuMax International . . . . . . . . . . . . . .1829 

VEDALAB . . . . . . . . . . . . . . . . . . . . . . . . . .1865 

ViraCor Laboratories . . . . . . . . . . . . . . . .666 

Vircell S.L. . . . . . . . . . . . . . . . . . . . . . . . . . . .351 

ViroStat, Inc. . . . . . . . . . . . . . . . . . . . . . . . .149 

Visgeneer Inc. . . . . . . . . . . . . . . . . . . . . . .1569 

Vista Technology Inc. . . . . . . . . . . . . . . . .568 

VistaLab Technologies, Inc. . . . . . . . . .2248 

Vital Diagnostics . . . . . . . . . . . . . . . . . . .3403 

Vonco Products . . . . . . . . . . . . . . . . . . . . .119 

VR2M . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1361 

VWR International . . . . . . . . . . . . . . . . . .1956 

W.B. Saunders/Mosby . . . . . . . . . . . . . .2811 

Wako Diagnostics . . . . . . . . . . . . . . . . . .1530 

Warde Medical Laboratory . . . . . . . . . . .962 

Waters Corporation . . . . . . . . . . . . . . . . .3820 

Web Industries Inc. . . . . . . . . . . . . . . . . .2263 

Welch Allyn, Inc. . . . . . . . . . . . . . . . . . . . .4228 

Wescor, Inc. . . . . . . . . . . . . . . . . . . . . . . . .3005 

WesTgard QC, Inc. . . . . . . . . . . . . . . . . . .1445 

Whatman Inc. . . . . . . . . . . . . . . . . . . . . . .3225 

Wheaton Science Packaging . . . . . . . .1952 

Wiener Laboratorios SAIC . . . . . . . . . .1452 

Wisepac Active Packaging 

Components Co. . . . . . . . . . . . . . . . . .3047 

Wondfo Biotech Co., Ltd. . . . . . . . . . . .1962 

Worthington Biochemical 

Corporation . . . . . . . . . . . . . . . . . . . . . .2161 

WSLH Proficiency Testing . . . . . . . . . . .2452 

Xceed Molecular . . . . . . . . . . . . . . . . . . .2155 

Xema-Medica Co., Ltd. . . . . . . . . . . . . . .1564 

Xiril . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3623 

YD Diagnostics . . . . . . . . . . . . . . . . . . . . .3630 

Yuhan NHS . . . . . . . . . . . . . . . . . . . . . . . . .1565 

Zebra Technologies . . . . . . . . . . . . . . . .4111 

Zentech . . . . . . . . . . . . . . . . . . . . . . . . . . . .1232 

ZeptoMetrix Corporation ...........2259 

Zeta Corporation . . . . . . . . . . . . . . . . . . .1924 

ZheJiang Gongdong Medical Plastic Fac- 

tor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .217 

ZheJiang U-Real Medical Tech. Co., Ltd. 107 

As of June 6, 2008

Low Resource Can Be High Quality 

Global healthcare, from page 1 

Organizing Committee, since she volunteered 

in Eritrea in 2006. She worked with 

a group of volunteers called Pathologists 

Overseas, who conduct training and help 

arrange for supplies and equipment to improve 

pathology and diagnostic services in 

developing countries. “I taught the medical 

students in their new medical school, and it 

really opened my eyes about global healthcare,” 

Gronowski said. “We don’t think 

about global healthcare, or everybody else’s 

health, on an everyday basis. We focus 

on our own little world. But to think that 

the health of people all around the world 

doesn’t affect us is like putting your head 

in the sand.” Gronowski is an Associate 

Professor of Pathology and Immunology, 

Obstetrics and Gynecology at Washington 

University School of Medicine in St. Louis. 

Gronowski spearheaded the effort to 

bring global health to the forefront of the 

educational program this year, starting with 

the opening plenary by Roy Vagelos, MD, 

former CEO of Merck & Co., who played 

a key role in providing free drugs to treat 

river blindness in developing countries. 

Then on Tuesday morning, Mark Perkins, 

PhD, chief scientific officer of the Foundation 

for Innovative New Diagnostics 

(FIND) will delve into the technical needs 

for IVDs in developing countries. Later, a 

full-day symposium, “Challenges in Global 

Infectious Diseases,” will tackle emerging 

global health issues and what strategies 

governments and NGOs are using to build 

up laboratories in low-resource settings. 

Smaller is Better 

With funding from the Bill & Melinda 

Gates Foundation, Yager’s lab is leading a 

collaboration with the Stayton lab at the 

University of Washington, PATH, Nanogen, 

and Micronics to develop a POC diagnostic 

platform for low-resource settings 

that can diagnose a wide range of diseases 

using parallel, nucleic acid-based assays, 

and immunoassays. 

The instrument, with an internal working 

name of the DxBox, features a compact, 

portable, shoe box-size reader, as well as 

disposable “lab cards” that use microfluidic 

circuits to perform up to six different tests 

from a few drops of blood. Importantly, 

all of the necessary reagents and buffers 

will be in a form that allows the cards to be 

stored for up to a year at ambient temperatures, 

and all sample cleanup and metering 

takes place within the card. “A capability 

that could not possibly have been extended 

to the developing world because of limitations 

of power, cost, reagent delivery, reagent 

storage, cold chain limitations, and 

transportation limitations—these things 

are now possible,” said Yager. “We can really 

extend some of our most sophisticated 

mechanisms of diagnosing disease to the 

remote ends of the diagnostic world. It’s 

not like we have to send the developing 

world our lowest quality, mediocre test— 

we can actually send them some of the best 

tests. That’s pretty exciting, particularly on 

the nucleic acid side.” The initial panel of 

tests on the cards will diagnose rapid-onset 

fevers, such as malaria, dengue, measles, 

Rickettsia, and Salmonella. 

The DxBox tackles many of the problems 

inherent to low-resource testing: lack 

46 CliniCal laboratory news June 2008 

of reliable power, harsh environments, and 

a dearth of trained personnel available to 

draw blood, perform testing, or maintain 

equipment. “Having been to Africa myself, 

you realize they have way different 

needs than we do,” said Gronowski. “Both 

their instruments and their reagents are 

frequently exposed to huge fluctuations in 

temperature, or must endure a really sandy 

environment, or fluctuations in power 

supply—just extreme conditions. Also 

maintenance: when things break down in 

Eritrea, it’s days and days for a person they 

have in Africa to get there. So these have to 

be reliable instruments, and they have to be 

very easy to use. Moreover, quality control 

is often times not well understood, so these 

need to be very stable instruments that are 

very forgiving.” 

David Kelso, PhD, Associate Professor 

of Biomedical Engineering at Northwestern 

University, will moderate this afternoon’s 

“Diagnostics for the Developing 

World” session. He also stresses the need 

for simplicity. “The simpler you make the 

device, the more complexity that is in it. It’s 

either chemical complexity, or computer 

complexity, or mechanical complexity. You 

have to do something to make it simple to 

use,” said Kelso. “So a lot of times, that requires 

getting into new technologies that 

have never been applied to diagnostics in 

the developing world. You really have to 

push the technology a lot further in these 

settings than you do for the developed 

world.” Current rapid tests used in lowresource 

settings include lateral flow strips 

or immunochromatographic strips that 

are generally qualitative, can be stored for 

long periods of time, and are relatively inexpensive. 

However, these strips have not 

lived up to expectations, mainly due to user 

error. “What people have found is that the 

performance of those tests is often not as 

good in developing world circumstances 

as they are back in the labs,” said Yager. “So 

one of the things we’re attempting to do is 

minimize the amount of user intervention 

required, so that user variability is no longer 

a factor, and environmental variability 

is not as much of a factor as it would be 

otherwise.” 

A Spectrum of Needs 

Kelso also emphasized another factor in 

low-resource diagnostics: understanding 

the unique needs of each country or setting. 

“Really understanding what the customer 

requirements are is the top challenge 

in developing low-resource diagnostics, in 

the very broadest sense,” said Kelso. “We 

think a point-of-care test, taking it right 

out to primary care, would be the best solution. 

But you go out to those primary care 

developed by a collaboration of paul yager’s and patrick stayton’s 

labs at the university of Washington, along with paTh, nanogen, and 

Micronics, this shoe box-sized platform, called the dxbox, employs 

advanced microfluidic technology to offer reliable and low-cost testing 

for a wide range of diseases. The system uses credit-card sized, disposable 

‘lab cards’ that perform up to six tests from a small patient sample 

for pocT in low-resource settings. 

sites, and a lot of times there isn’t somebody 

there that is certified to draw blood. 

So then you follow the patient to when they 

get tested, and it’s at a district hospital, and 

that’s not where we envisioned the test. So 

we’re trying to understand the structure of 

how care is delivered and what resources 

are in what locations.” 

Yager’s focus is on delivering POC tests 

in low-resource settings that can be used 

by anybody. “Clearly there is a range of circumstances 

in the developing world. The 

cities often have nicely equipped hospitals 

and laboratories with power and most 

everything else they need, but the issues 

you have tend to mostly be in remote 

areas, where you don’t have continuous 

power, where you may not have air conditioning, 

and where you probably don’t 

have highly-trained technicians and can’t 

get supplies in on a regular basis.” However, 

Yager noted that instruments such as the 

DxBox can attend to needs across the spectrum. 

“The particular things that people 

want depends on the particular end user. 

Some of the people in the more sophisticated 

hospitals want quantitative results; 

the people in the lowest socioeconomic 

levels generally are looking at the quick 

and qualitative answer, like ‘Is it malaria or 

isn’t it?’ Not ‘How much malaria?’—just 

‘Which drug do I use to treat the patient as 

quickly as possible before they go home?’ 

Turnaround is a very big deal in all these 

locations.” 

Coming Soon to a Clinic Near You? 

Although the DxBox and other POC instruments 

being developed for low-resource 

settings aim mainly to overcome 

environmental, economic, and personnel 

problems much different from those in 

U.S. labs, Kelso and others stress that these 

cutting-edge technologies will likely become 

very useful in developed countries 

in the near future as our healthcare system 

changes and evolves. “One trend that’s 

obvious is these clinics that are starting to 

appear in Wal-Mart and all kinds of alternative 

sites,” said Kelso. “They are, in my 

mind, a lot like the walk-in clinics over in 

Africa. It’s not low-resource, but it’s a situation 

where it’s incredibly important to get 

the results of your diagnostic test while the 

patient is right there. There are lots of situations 

where having a rapid, point-of-care 

test improves the ability of the physician to 

treat the patient.” 

Other potential uses of speedy and inexpensive 

low-resource methods include 

non-traditional healthcare settings like 

natural disasters, suggested Kelso, such as 

after a hurricane, when the usual laboratory 

infrastructure is wiped out. Mobile clinics 

or storefront clinics in impoverished areas 

could use them as well. Yager also put forward 

that hospitals might want something 

like his DxBox in certain circumstances. 

“Being able to have a rapid, nucleic acidbased 

test that can be done at the point-ofcare 

is really a critical capability. And if you 

do that, you don’t want the instrument to 

be incredibly expensive, because hospitals 

can’t afford to put in a large number of 

extremely expensive instruments that duplicate 

capabilities in the centralized lab. So 

the development of these technologies for 

point-of-care use in the developing world 

enables the cost to be driven down far 

enough that you can bring the technology 

back to sites in the developed world.” 

Low-resource-type diagnostics might 

also someday become routine in developed 

countries who increasingly are seeking 

ways to care for poor and uninsured citizens. 

“Eventually our healthcare system is 

going to evolve to take care of the 40 million 

poorest people, and they’re probably 

not going to be cared for in the same way 

that the richest 40 million are cared for,” 

noted Kelso. “So those clinics, those healthcare 

delivery systems are going to be different 

and will have functional aspects of the 

way South Africans or Ugandans take care 

of their population.” 

Shifting to a Global Health Perspective 

Although global healthcare doesn’t always 

mean low-resource healthcare, it does represent 

a different world view when it comes 

to laboratory medicine. “I would challenge 

people to think about more than just themselves 

in what they perceive as their immediate 

patient base,” said Gronowski. “We in 

healthcare have to take responsibility for 

the health of the world. In the long run, I 

believe it will affect the people in your small 

circle. If the health of people worldwide is 

good, then I don’t have to worry about 

Ebola virus, and bird flu, and SARS. I think 

we have to be knowledgeable about global 

health so that we can perhaps help others, 

but then ultimately down the road, to help 

ourselves as well.” cln

industry Workshops, continued from p. 6 

Wednesday, july 30 

7:00 a.m.–8:30 a.m. 

DENKA SEIKEN Co., Ltd. 

Small, Dense LDL Cholesterol and Heart 

Disease Prediction: Results from Framingham 

Speaker: Ernst J. Schaefer, MD, Professor and 

Senior Scientist, Tufts University School of 

Medicine 

Grand Hyatt Washington, Independence B 

Diagnostic Consulting Network 

Application of Fluorescence in Next 

Generation Lateral Flow Assays 

Speakers: Brendan O’Farrell, PhD, President, 


Jeff Bauer, Executive Vice President, R&D, 


Renaissance Hotel, Meeting Room 12, 13 

Roche 

Prepare for the Changes in Hepatitis C 

Speakers: Brigitte Fernandes-McAlear, MBA, 

Group Marketing Manager, Roche Diagnostics 

Corporation 

Bryan Cobb, PhD, FACMG, Manager 

Clinical and Scientific Affairs, Roche 

Diagnostics Corporation 

Steve Rossi, PharmD, Roche Molecular 

Diagnostics 

Renaissance Hotel, Meeting Room 16 

Roche/OraSure 

The Value of Oral Fluid Testing 

Speakers: Edward J. Cone, PhD, 

Penney Associates, Scientific Advisor 

R. Sam Niedbala, PhD, Lehigh University, 

Professor, Department of Chemistry 


Roche 

Vitamin D 101: Clinical Utility of Monitoring 

Vitamin D3 in the General Public 

Speakers: Robert P. Heaney, MD, FACP, 

FACN, John A. Creighton University, Professor 

of Medicine, Department of Medicine. 

TBD 


Roche 

Maximizing the Effectiveness of Your 

Intraoperative PTH program: Interpreting the 

New NACB Guidelines—The Lab and 

the Surgeon Perspective 

Speakers: Lori J. Sokoll, PhD, FASB, 

John Hopkins Medical Institutions, 

Associate Director of Clinical Chemistry, 

Department of Pathology 

Robert Udelsman, MD, MBA, FACS, 

William H. Carmalt Professor of Surgery, 

Chairman of Surgery, Chief, Surgery, 

Yale-New Haven Hospital 

Grand Hyatt Washington, Constitution D, E 

Sebia Electrophoresis 

The Diagnosis of Hemoglobinopathies and 

Thalassemias Utilizing Capillary Zone 

Electrophoresis Technology: Case Studies and 

Comparisons to Traditional Methodologies 

Speakers: Edward Wong, MD, Director of 

Hematology, Associate Director of Transfusion 

Medicine, Children’s Nation Medical Center 

Aigars Brants, PhD, Scientific Affairs Manager, 

Sebia Electrophoresis 

Grand Hyatt Washington, Farragut Square 


High Sensitivity Troponin—Delivering 

Value for Chest Pain Management 

Speaker: Theresa Spence, Siemens Healthcare 

Diagnostics 

Grand Hyatt Washington, Independence F 


Trends in Immunosuppressive Drug Use and 

Cost-Effective Monitoring of Immunosuppressive 

Drugs at the Local Community Level 

Speaker: Kelli Ryzewski, 


Grand Hyatt Washington, Independence H 

Sysmex America, Inc. 

Sysmex XT-V Multi-Species 

Hematology Analyzer 

Speakers: Andrew R. Hay, Senior Director, 

Health System Sales, Sysmex America, Inc. 

Susan A. Vuylsteke, MD, Account Executive, 

Comparative Hematology, Sysmex America, 

Renaissance Hotel, Congressional Hall A 

Whatman, Inc. 

Blood Separation for Rapid Diagnostics: 

Principles, Materials, and Practice 

Speaker: Vincent A. Sy, Whatman, Inc., 

Technical Marketing, Manager 

Grand Hyatt Washington, Constitution C 

6:00 p.m.–7:30 p.m. 


Advances in the use of LC/MS/MS 

for Toxicology Analysis 

Speakers: TBD 

Grand Hyatt Washington, 

Independence G, H, I 

Dawning Technologies, Inc. 

Advanced Applications of 

Dawning Middleware 

Speakers: John Selmyer, President, Dawning 

Technologies, Inc. 

Greg Schallert, Engineering Manager, Dawning 

Technologies, Inc. 

Grand Hyatt Washington, 

Constitution C & Corridor C 

Luminex 

Enhanced Detection of Respiratory Viruses 

Using the Luminex xTAG RVP Assay 

Speaker: Dr. Christine Ginocchio, Director 

of Microbiology and Molecular Diagnostics, 

Northshore Long Island Jewish Hospital 

Renaissance Hotel, Grand Ballroom East 

Ortho-Clinical Diagnostics, co-sponsored by 

bioMérieux and Roche Diagnostics 

Clarifying the Role of 

NT-proBNP by Consenus 

Speakers: TBD 


Osmetech Molecular Diagnostics 

Latest Developments in the 

Pharmacogenetics of Warfarin 

Speaker: Michael D. Caldwell, MD, PhD, 

FACS, Marshfield Clinic 


Randox Laboratories Ltd. 

Biochips Can Save Lives—Cardiovascular 

and Cerebrovascular Disease 

Speakers: Dr. Peter Fitzgerald, Managing 

Director, Randox Laboratories Ltd. 

John Lamont, Chief Scientific Officer, 

Randox Laboratories Ltd. 

Renaissance Hotel, Congressional Hall A 

Roche 

Scott and White HAI Control 

and Screening Program 

Speaker: Arundhati Rao, MD, Section Chief, 

Technical Pathology and Molecular Genetics, 

Scott and White Hospital 

Grand Hyatt Washington, Independence D, E 


Non-Invasive Markers of Liver Fibrosis—Why 

Are They Needed? 

Speaker: Andrew Beard, Siemens Healthcare 

Diagnostics 



The A, B, and C’s of In Vitro Allergy Testing 

Speakers: TBD 



Trends in Infectious Disease Testing: 

A Conversion of Technologies to 

Meet the Emerging Threat 

Speakers: Katherine Soreng, 


Grand Hyatt Washington, Independence B 


From Biomarker Discovery to Routine 

Assay-LCMS in Clinical Research Laboratories 

Speakers: Dr. Mary Lopez, Director, 

Biomarker Discovery Institute 

Dr. Ravinder Singh, Director, Endocrinology 

Laboratory, Mayo Clinic 

Dr. Donald Chace, Laboratory Director, 

Pediatric Medical Group 

Grand Hyatt Washington, Constitution D, E 

Third Wave Technologies 

Third Wave’s HPV Clinical Trial Results 

Speakers: TBD 


As of May 14, 2008 

index To adverTisers 

please thank these advertisers by telling them you saw their 

advertisement in Clinical Laboratory News. 

3M Medical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 

AutoGenomics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 

Bio-Rad . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 

Chromsystems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 

College of American Pathologists . . . . . . . . . . . . . . . . . . . . . . . 27 

Fluid Metering (OEM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 

Gerresheimer Wilden . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 

Hoover Precision Prods (OEM) . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 

Instrumentation Laboratory ............................. 40 

Lifescan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13 

Midland BioProducts (OEM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 

Mindray ................................................ 15 

Olympus America ...................................24 & 25 

Ortho-Clinical Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 

Proliant Health & Biologicals ............................. 34 

Randox . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 

Roche Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 & 5, 21, 29 

Siemens Medical . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48 

Sysmex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 

Tosoh Bioscience ........................................ 31 

Wheaton Science Pkg (OEM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 

�� 

�� 

�� 

�� 

�� 

new Titles from 

aacc press 

Visit the AACC Bookstore to see the 

latest releases from AACC Press. 

dna from a to Z & back again 

Carol A. Holland and Daniel H. Farkas 

2008, 191 pages, softcover 

ISBN 9781594250880 

Product #5104 

handbook of diagnostic 

endocrinology, second edition 

Edited by William E. Winter, 

Lori J. Sokoll, and Ishwarlal Jialal 


ISBN 9781594250866 

Product #5105 

self-assessment in 

clinical laboratory science ii 

Edited by Alan H.B. Wu 


ISBN 9781594250873 

Product #5106 

Quick Guide to clinical chemistry 

Q U I C K G U I D E T O 


Janelle M. Chiasera, Robert W. Chemistry Hardy, 

Janelle M. Chiasera 

Robert W. Hardy 

John A. Smith 

and John The Quick Guide to Clinical A. Chemistry Smith 

is a pocket-sized 

reference intended for physicians, nurses, physician 

assistants, nurse practitioners, medical technologists, 

pharmacists, and residents and students in those professions. 

This guide focuses on the selection and use of chemistry 

laboratory tests for diagnosing and managing emergent 

conditions such as poisonings, acute abdominal pain, and 

acute myocardial infarction. 


The guide's small size allows it to be used in situations when 

quick decisions must be made regarding the ordering and 

interpretation of chemistry tests. The emergent clinical 

conditions and the associated laboratory tests are described 

together for quick reference. 

Although this Guide reviews several clinical conditions, it is 

not intended to be a comprehensive guide to all clinical 

ISBN 9781594250729 

laboratory tests, nor is it intended to dictate what constitutes 

reasonable, appropriate, or best care in a given situation. 

Comprehensive 

references for such 

information currently 

exist. Instead, it should be 

seen as it is clearly 

named, a “Quick Guide” 

Product #4631 

to clinical chemistry. 

HANDBOOK OF 

DIAGNOSTIC 

ENDOCRINOLOGY 

after the show—Two easy Ways to order 

Online: www.aacc.org 

Phone: Call AACC (1(800) 892-1400 and place your order directly with an 

AACC customer service representative. Have your credit card ready. 

coming soon… 

Applying Evidence-Based Laboratory Medicine: A Step-by-Step Guide 

Christopher P. Price and Robert H. Christenson 

Brain Biomarkers for Cerebral Ischemia: NMDA Neuroreceptors Degradation and Blood 

Assay Development, Svetlana Dambinova 

Handbook of Workplace Drug Testing, Second Edition 

edited by Jeri D. Ropero-Miller and Bruce A. Goldberger 

SECOND EDITION 

CliniCal laboratory news June 2008 47 

EDITED BY 

WILLIAM E. WINTER, 

LORI J. SOKOLL, 

ISHWARLAL JIALAL, 

Q U I C K G U I D E T O 

ELECTROLYTES 

ASPARTATE AMINOTRANSFERASE 

ALANINE AMINOTRANSFERASE 

GAMMA-GLUTAMYL Clinical 

TRANSFERASE 

LIPASE 

GASTRINChemistry 

ACETAMINOPHEN 

CREATINE KINASE 

BRAIN NATRIURETIC PEPTIDE 

TROPONINS 

BLOOD UREA NITROGEN 

CREATININE 

OSMOLALITY 

CORTISOL 

BLOOD GASES 

GLUCOSE 

ANION GAP 

BILIRUBIN 

AMMONIA 

THERAPEUTIC DRUG MONITORING 

PHOSPHATIDYLGLYCEROL 

Janelle M. Chiasera 

FETAL FIBRONECTIN 

Robert W. Hardy 

John A. Smith 

THYROID STIMULATING HORMONE 

THYROID ANTIBODIES

Download the Monday Daily - American Association for Clinical ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?